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INSIGHTS INTO ENZYMATIC MANIPULATIONS OF NUCLEIC ACIDS 
 
This dissertation details three studies dealing with the manipulation of nucleic 
acids. In the first investigation, each of the four natural nucleobases were analyzed for the 
ability to serve as a universal template at the ligation junction of a T4 DNA ligase 
reaction. This resulted in the first instance of sequence-independent ligation catalyzed by 
any DNA ligase. Although all of the nucleobases display universal templating 
capabilities, thymidine and guanosine provided the most effective results. In addition, 
lowered MgCl2 and ATP concentrations, as well as the inclusion of DMSO, also aided in 
the sequence-independent ligation reported here. In the course of these studies, current 
methods of removing urea from denaturing-gel purified nucleic acids proved 
cumbersome. Therefore, in the second study simple butanol extraction was examined as a 
means to eliminate urea from nucleic acid solutions. Stepwise butanol extraction was the 
most effective approach to solving this problem and provided a much needed technique 
for nucleic acid purification. This type of extraction also does not result in significant 
losses of nucleic acid sample. The third study exploits the molecular recognition and 
catalytic properties inherent in an autocatalytic group I intron to develop a ribozyme that 
can replace the 5' end of an RNA substrate with a different RNA. This 5' replacement 
splicing reaction can potentially repair mutations on the 5' ends of RNA transcripts that 
lead to a variety of genetic mutations. The model system was a common mutation in a 
small model mimic of the k-ras gene in vitro, which predisposes individuals to lung 
cancer. This 5’ replacement splicing reaction occurred in vitro using this small model 
system; the reaction was also enhanced by the alteration of the molecular interactions 
involved. The results and implications of each of these studies are detailed in this 
dissertation. 
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Chapter 1 - Introduction 
 
 The two types of nucleic acids, DNA (deoxyribonucleic acid) and RNA (ribonucleic 
acid), are mainly responsible for the storage and transmission of genetic information; however, 
the catalytic and regulatory capabilities of nucleic acids continue to be explored (1-7). In this 
dissertation, studies of nucleic acid manipulation via protein and RNA enzymes, or catalysts, are 
detailed. 
Ligases are enzymes that are necessary for certain cellular processes, such as DNA 
replication and repair; DNA ligases join two neighboring nucleic acids that are base-paired to a 
nucleic acid template, forming a duplex (8-11). This site of ligation is called a nick. In general, 
complementary base-pairing in this interaction is assumed to be preferred for ligation; this 
preference for complementary base-pairing is termed fidelity (12). Since ligases play an 
important role in living organisms, a higher level of fidelity is imperative in the maintenance of 
genome integrity (12). Ligases with lowered fidelity, however, could be utilized for site-directed 
mutagenesis or sequence identification procedures (13-15). DNA ligases have been tested for 
their ability to ligate nicks in duplexes containing mispairs and were found to be tolerant of 
particular mispairs in the duplex; yet no ligase exhibiting complete sequence-independent 
ligation at or adjacent to the nick has been reported (13-14, 16-26).  The first study reported here 
tested the ability of each of the natural DNA nucleobases (adenosine, cytosine, guanosine, and 
thymidine) to act as universal templates in ligation under specific reaction conditions. This 
universal templating ability would result in ligation independent of the sequence of the bases at 
or adjacent to the site of ligation. The work presents information on ligase fidelity, as well as 
nucleic acid abilities. This insight can be used to study or modify the behavior of either or both 
of these factors. The process used and the results obtained are explained in this dissertation. 
 In the process of dealing with nucleic acids, methods for their purification become 
necessary. Such methods often use high levels of urea, a common denaturant of biomolecules 
(3). Much of this urea remains in the purified nucleic acid samples. Unfortunately, the presence 
of urea in these samples can cause problems with the folding of nucleic acids and the resultant 
structures (27-28). Current ways to remove urea, such as ethanol precipitation and 
chromatography, can be ineffective and expensive. The second study in this dissertation focuses 
on the development of a simple and effective technique for the removal of urea in such 
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situations. Extractions of nucleic acids samples were performed with 2-butanol and evaluated for 
their ability to efficiently and reproducibly eliminate urea from the samples; the findings are 
elaborated upon here and present a more than suitable method for urea removal.  
 As stated above, nucleic acids contain and transmit genetic information; however, they 
have been and continue to be investigated with regard to catalysis and regulatory abilities in 
cellular processes (5-7, 29-30). Catalytic RNA was first reported in the 1980’s with the discovery 
of a self-splicing group I intron and the characterization of the catalytic component of Rnase P, 
which is composed of RNA (3, 6). Group I introns reside in pre-rRNA transcripts and catalyze a 
self-splicing reaction in which they are removed from the transcript and the flanking exons are 
ligated together (1, 3, 5). These introns use molecular interactions (the P1, P9.0, and P10 helices) 
to catalyze this reaction (31-32). When the exons are eliminated from the transcript, the 
remaining intron can utilize those same interactions to catalyze new reactions on exogenous 
substrates (28, 33-34). The new catalytic entity is termed a ribozyme, or RNA catalyst. Such 
ribozymes have been derived from group I introns and reported to catalyze new reactions. These 
include reactions that result in the excision of sequences from an RNA substrate (trans excision-
splicing) or the replacement of the 3’ portion of an RNA transcript (trans-splicing or ribozyme-
mediated 3’ replacement) (29, 33). These reactions provide new methods to alter RNA 
sequences. These reactions also provide a possible means to correct genetic mutations that are 
linked to disease prior to the translation of RNA into protein (32). The replacement of the 5’ 
portion of an RNA transcript via a ribozyme-catalyzed reaction has, however, not been reported. 
The third investigation included in this dissertation centers on the development and analysis of a 
new ribozyme-catalyzed reaction that can replace the 5’ portion of an RNA substrate. Such a 
reaction would also possess therapeutic possibilities in cases of genetic mutations that are 
implicated in disease, but may not be corrected by trans-excision splicing or trans-splicing. This 
study involves the design of such a reaction system and its implementation in a small in vitro 
model system, as well as its further study with respect to the previously mentioned molecular 
interactions. The investigation imparts additional knowledge of the workings of group I intron-
derived ribozymes and the opportunities for disease treatment they may provide. 
 3
Chapter 2 - Background 
 
  
2.1 Nucleic acid composition 
2.1.1 DNA 
 Deoxyribonucleic acid, a biological polymer, consists of monomeric units termed 
nucleotides. Each of these units contains a phosphate group, a deoxyribose molecule (a sugar), 
and a nitrogenous base (1-4). The nucleotides of DNA are divided into two categories based on 
what type of nitrogenous base is present. Adenine and guanine are purines, while cytosine and 
thymine are pyrimidines (Figure 2.1). These designations refer to the base component of the 
nucleotide; however, the entire monomer units are called adenosine, guanosine, cytidine, and 
thymidine. Each nucleotide also has a single letter abbreviation as shown in Figure 2.1. Please 
note that deoxyribose refers to the lack of a hydroxyl at the 2’ position of the sugar (1-3).  
 When the nucleotides of DNA are linked, they form a chain, or strand. The nucleotides in 
the strand are covalently attached through phosphodiester bonds between the phosphate group of 
one nucleotide and the 3’ OH of the adjacent nucleotide, as shown in Figure 2.2A (1-4). Since 
this linkage occurs from the 5’ phosphate of one to the 3’ OH of another, its direction is 
designated as 5’ to 3’. DNA in its native form, however, exists as a double strand, or helix. This 
helix is formed through base-pairing, which are hydrogen-bonding interactions between the 
bases of the nucleotides. Complementary base-pairing results in A forming two hydrogen bonds 
with T, while G forms three hydrogen bonds with C (Figure 2.2B). The two strands in the helix 
are antiparallel, meaning that they run in opposite directions. One is oriented in the 5’ to 3’ 
direction, while the opposite strand is in the 3’ to 5’ direction (1-4). When shown as a two-
dimensional structure, as in Figure 2B, the helix resembles a ladder. The sugar-phosphate 
linkages, or backbone, form the sides of the ladder. The bases, paired complementarily, form the 
rungs of the ladder. In a three-dimensional depiction, however, the double helix takes on a more 
coiled form (1, 3).  
 
2.1.2 RNA 
 In terms of composition, RNA differs from DNA in that 1) the sugar in RNA has a 2’ 
hydroxyl (hence, ribonucleic acid) and 2) it uses the pyrimidine uridine (U) in place of 
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thymidine (Figure 2.3A) (1-4). As for how RNA exists in nature, it is usually single-stranded. 
The strand can fold back on itself, resulting in a great deal of secondary structure, often in the 
form of helical regions containing base-paired stems and unpaired loops (Figure 2.3B) (3). 
 
2.1.3 Nucleic acid terminology 
 For the purpose of clarity, common terms used in this dissertation when referring to 
nucleic acids will be explained here. While nucleotide refers to a phosphate group, a pentose 
molecule, and a purine or pyrimidine, the terms nucleoside and nucleobase refer to the connected 
pentose and base only (3, 35). An individual nucleotide in a strand of DNA or RNA can also be 
referred to as a residue (1-4, 35). Oligonucleotide or oligomer can refer to a single strand of 
DNA or RNA, which can be synthetic (35). The term DNA, itself, is sometimes used to refer to a 
single strand, as is RNA. Oligonucleotides may also be denoted as DNA or RNA molecules (2-
4). When speaking of a DNA in the form of a double helix, the term duplex is also used (1-4).  
 
2.1.4 Nucleic acids in molecular biology 
 Genetic information is encoded in specific sequences of DNA nucleotides. This 
information establishes and preserves the biological functions and processes of a living organism 
(3-4). The central dogma of molecular biology, shown in Figure 2.4, provides a general diagram 
for the procession of events leading from nucleic acids to proteins, which are macromolecules 
responsible for much of the cell’s activity. The synthesis of DNA is termed replication and 
requires DNA-dependent polymerases, which are enzymes that catalyze the polymerization, or 
joining of nucleotides (1-4). Polymerases also play a part in the next part of the process, which is 
the transcription of DNA into RNA. Genes, which are particular sequences of DNA that 
compose an individual genetic element, can code for protein or for particular RNAs (1-3). There 
are three main types of RNAs, messenger RNA (mRNA), ribosomal RNA (rRNA), and transfer 
RNA (tRNA) (1-4).  In the progression of nucleic acids to protein, DNA is transcribed into 
mRNA, and this new RNA is called a transcript. This transcript, the pre-mRNA, undergoes 
posttranscriptional modification to become a mature RNA, prior to its translation into protein. 
This modification includes the removal of intervening regions not present in the mature RNA. 
These regions, introns, can be found in other types of RNA, but in the case of mRNA, they are 
spliced out and the remaining regions that will be expressed, or translated into protein (exons, 
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shown in gray) are joined to form a mature RNA transcript (1-4). This processing is done by the 
spliceosome, a complex composed of protein and RNA, (shown in Figure 2.5). Note that 
although the spliceosome construct is not shown, it mediates the splicing event (1-3). The exons 
are shown in black and the intron in gray. The first event in this type of splicing occurs through 
the attack of a conservd adenosine in the intron on the 5’ end of the intron. The freed 3’ OH of 
the terminal base on the 5’ exon attacks the 3’ exon. This results in exon ligation and the removal 
of the intronic regions (1-3). 
The mature transcript is translated into protein at the ribosome, a ribonucleoprotein 
(made of protein and rRNA) complex. To understand translation, one must understand how 
proteins are coded in DNA and RNA. Codons are sequences of three nucleotides that specify a 
particular amino acid (Figure 2.6). Just as there are four nucleotides in the nucleic acid 
“alphabet”, there are twenty amino acids that compose the protein “alphabet” (1-4). Three 
nucleotides per codon result in 64 combinations. Since only twenty amino acids are possible, the 
code is repetitious. Other than the single codon that signal the start of transcription and the 3 
codons that signals only the end of transcription, each amino acid has multiple corresponding 
codons. This is called the redundancy of the genetic code (2). In the genetic code, the 
corresponding amino acid of a codon is determined mainly from the first two nucleotides. The 
third position in the codon, also termed the wobble position, can in most cases be any one of the 
four nucleotides without altering the amino acid identity of the codon (1-3). During translation, 
each codon in the mRNA pairs with three complementary nucleotides present in a tRNA 
molecule; this tRNA has the corresponding amino acid attached to it. The ribosome catalyzes the 
joining of the amino acids to yield the resultant protein product (1-3). 
 
2.2 Nucleic acids and enzymes 
Since genetic information is stored in DNA and transcribed into RNA prior to its 
expression into protein, a great deal of investigation into biological systems requires the 
manipulation of nucleic acids. This manipulation can be done to study DNA or RNA itself, as 
well as its interaction with other biomolecules. Nucleic acids are the natural substrates for many 
enzymes, such as polymerases and ligases (1-4). Many studies analyze or manipulate the 
behavior of the natural, or canonical, nucleobases in reactions that use these enzymes (1-4). 
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Some of these investigations include mutagenesis (altering a given genetic sequence), detection, 
and the study of enzymatic processes (1-4).  
 
2.2.1 Enzymatic ligation 
The process of ligation, in terms of nucleic acids, can occur chemically or enzymatically 
(3, 9-13, 37-42). The oligonucleotides ligated in the reaction can be DNA or RNA (1-3). The 
enzyme catalyzes the joining of an acceptor oligonucleotide, which contains a required 3’ OH 
group, and a donor oligonucleotide, which contains a required 5’ phosphate, as shown in Figure 
2.7 (3, 9-12). This ligation junction between the oligonucleotides is referred to as a nick and the 
oligonucleotides being joined may need to be base-paired with a template molecule (3). As is the 
case with many enzymatic reactions, a cofactor is required; a cofactor is a nonprotein component 
that participates in the reaction. Cofactors can be metals or organic molecules and aid in 
reactions that proteins may not be suited for, such as oxidation-reduction reactions or the 
transfers of functional groups (3). Ligases, specifically, use ATP (adenosine triphosphate) or 
NAD (nicotinamide adenine dinucleotide) as cofactors. Which cofactor is needed depends on the 
source of the enzyme (3, 9, 43). Ligases generated in eukaryotic cells generally require ATP; 
those obtained from prokaryotic cells use NAD. The mechanism for the enzymatic ligation 
reaction, using ATP as a cofactor, is depicted in Figure 2.7. The reaction involves 1) the 
activation of the enzyme with the formation of a enzyme-AMP (adenosine monophosphate) 
construct with the attendant release of PPi 2) transfer of AMP to the donor oligonucleotide, 
creating an intermediate, and 3) ligation of the donor oligonucleotide to the acceptor 
oligonucleotide via a transesterification reaction, resulting in the release of AMP (1-3). Ligases 
also require divalent cations for their activity, usually Mg2+ (1-4, 9-12).  DNA ligases can also 
catalyze the AMP-dependent reverse reaction, which creates nicks in DNA (43).  
As stated above, the substrate for ligase can be DNA or RNA. While some of these 
ligases can ligate single-stranded oligonucleotides, those discussed here will be DNA ligases that 
require that the oligonucleotides are, at least partially, base-paired with a template molecule. The 
preference for this base-pairing to be complementary is referred to as the fidelity of DNA ligases. 
Since ligase is an essential enzyme in vivo, its fidelity is essential to maintaining genetic integrity 
in DNA repair, recombination, and replication (12). A low level of fidelity in such an enzyme 
could lead to high levels of mutagenesis. Ligases also play a role in a wide variety of in vitro 
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biotechniques that require nucleic acid manipulation, including standard cloning protocols, the 
Ligase Chain Reaction (LCR) (44), and the Ligase Detection Reaction (LDR) (14, 45-46). High 
fidelity in these reactions is important for experimental accuracy. 
In alternate situations, however, ligases with low fidelity could also be useful for certain 
experimental strategies, including ligating together degenerate or unknown sequences for 
purposes such as site-directed mutagenesis or sequence identification (15-16). In this same vein, 
ligases are known to have the ability, at least in vitro, to ligate oligonucleotides that form certain 
mismatch base pairs with their templates, both at the ligation junction and at other positions in 
the resultant helices (14-15, 16-26). Ligases that show a complete lack of sequence specificity at 
and near the ligation junction, however, have not been reported. Chemical ligation, as opposed to 
enzymatic ligation, has also been studied; however, its fidelity has not been found to be any 
lower than that of ligases (37-42). Another way to secure such sequence-independent ligation 
would be to place universal bases (47) in the template molecule at the ligation junction.  
Universal bases are nucleoside analogs that bind each of the four canonical bases equally, 
although not necessarily tightly (48-50). In this way, ligases could use the universal template 
region to direct the ligation of oligonucleotides regardless of the terminal sequences being 
joined. Many universal base analogs, however, intercalate with DNA helices and may not 
actually participate in base-pairing and formation of the helices (49). Nucleoside analogs that 
actually function through hydrogen-bonding interactions have not been shown to do so equally 
with all four natural nucleobases (47). Some have even been shown to lower the melting 
temperatures for the duplexes in which they are incorporated and lower the complementary base-
pairing specificity of neighboring nucleotides (50). In addition, all available data indicates that 
known universal base analogs are not very effective in ligation reactions, especially at the 
ligation junction itself (48).  
In lieu of nucleotide analogs that can behave as universal bases at ligation junctions, one 
additional avenue to explore in the quest for sequence-independent ligation would involve 
canonical bases. While no ligases capable of complete sequence infidelity at the ligation junction 
have been reported, the natural nucleobases could possess universal base capabilities. Specific 
reaction conditions have been shown to alter the activity of some enzymes. DMSO (dimethyl 
sulfoxide) has been shown to cause ‘star site’ activity in some restriction enzymes; this results in 
a relaxation in restriction site sequence requirements (51-52). PEG (polyethylene glycol) is 
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widely recognized as a molecular crowding agent and is often used to increase the efficiency of 
enzymatic reactions (53). SSB (single-stranded binding protein) is required in hexamer ligation 
(54-55). As for DNA ligase, temperature and salt concentration have been shown to affect its 
fidelity (43). Thus, ample evidence exists that altering reaction conditions can alter enzymatic 
activity. Therefore, the first investigation systematically analyzed whether any of the four 
canonical bases could act as universal template bases at, and immediately adjacent to, a centrally 
located ligation junction under specific experimental conditions. T4 DNA ligase was chosen 
because of its easy availability and previous reports of its ability to ligate molecules with some 
mismatched base pairs (14-18, 19-21).  
 
2.3 Urea Extraction of Nucleic Acid Solutions 
2.3.1 Necessity of Urea Extraction 
 The study of nucleic acids requires methods to isolate and purify them once they have 
been manipulated in the desired fashion. One of the most common analytical and purification 
methods for nucleic acids is PAGE, or polyacrylamide gel electrophoresis (56). The high 
resolution (down to a single nucleotide) that this method provides makes it an attractive one for 
purification (3). PAGE gels, however, can contain high concentrations of urea (up to 8M); urea is 
a commonly used denaturant and gels containing it are referred to as denaturing gels (56). Many 
approaches used to study aspects of molecular biology require pure nucleic acids, including 
methods for radiolabeling, hybridization, primer extension, and most anything dealing with RNA 
and DNA molecules. After running a denaturing PAGE gel, the desired nucleic acid band is 
excised from the gel and then extracted from the gel slice, usually by a soaking method that 
allows the nucleic acid to diffuse out of the gel and into solution (56). Unfortunately, the urea 
contained within the gel slice also diffuses into solution with the purified nucleic acid. The 
effects of urea on nucleic acid folding, function, and catalysis can be substantial (27-28). 
Therefore, removing as much urea as possible from the nucleic acid preparation is necessary and 
benefits subsequent applications.  
 
2.3.2 Current Methods of Urea Removal 
Two of the most common methods for removing urea from nucleic acid solutions can be 
problematic. Ethanol precipitation uses ethanol and an added amount of salt to cause the 
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precipitation of nucleic acids in solutions (56). The nucleic acids are pelleted by centrifugation of 
the ethanol/nucleic acid solution. The pellet is washed with a lesser concentration of ethanol to 
remove any residual salt and the pellet is dried and reconstituted for further experimental use 
(56). At such high concentrations of urea as those used in denaturing gels, however, ethanol 
precipitation is likely to also result in the precipitation of the urea with the nucleic acid. 
Chromatography, an additional method for urea removal, utilizes separation based on molecule 
polarity. In the case of urea extraction, the columns necessary can be costly. Additionally, the 
strong polarity of urea when in solution can lead to the column being overloaded or ineffective 
Therefore, a simple and effective new strategy for removing urea from nucleic acid 
samples would be useful. The 2-butanol extraction of nucleic acid samples was investigated as 
an additional method to effectively extract urea from such solutions..  
 
2.4 Catalytic RNA 
 As mentioned previously, the first catalytic RNAs reported were a self-splicing group I 
intron from Tetrahymena thermophilus and the catalytic RNA subunit of Rnase P (6-7). RNase 
P, a ribonucleoprotein construct, cleaves the 5’ end of tRNA transcripts to yield mature tRNAs 
(Figure 2.8A) (3, 7, 57). Note that RNase P is shown as a general complex. Since those 
discoveries, other catalytic RNAs have been reported. These include the hammerhead, hairpin, 
and hepatitis delta virus (HDV) ribozymes, group II introns, and additional group I introns (3, 
58-61).  The term ribozyme is often used to refer to an RNA entity with catalytic activity (36). 
The hammerhead (Figure 2.8B), hairpin (Figure 2.8C), and HDV (Figure 2.8D) ribozymes are all 
found in viruses (parasitic entities consisting of genetic material encapsulated by a protein coat) 
and they range in length from 40 nucleotides to 160, respectively (58-61). Like Rnase P, they all 
catalyze cleavage reactions, though they adopt different secondary structures (Figures 2.8B, 
2.8C, and 2.8D). The substrate sequences are shown as dotted lines and the cleavage sites are 
denoted with arrows. The letter N denotes A, C, G, or U; D denotes A, C, or U. Each of these 
catalytic RNAs require metal ions for catalysis (58-61). In addition to these catalytic RNAs, 
there are also exist RNA molecules that possess regulatory and catalytic abilities, such as a 
glycine-dependent system recently reported (7).  
The hammerhead, hairpin, and HDV ribozymes provide therapeutic options in gene 
inhibition. In cases of viruses or defective genes that are linked to disease, elimination of the 
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complete functional genes by cleavage could provide amelioration or eradication of their effects. 
Studies in this vein have been done and reported to be successful in vivo (30, 36, 62-64).  
 
2.4.1 Intron self-splicing reactions 
Group I and group II introns are both capable of self-splicing reactions that remove them 
from RNA transcripts and ligate the remaining exons together (7, 36, 65-66). General diagrams 
for each self-splicing reaction are shown in Figure 2.9; both of these reactions require metal ions 
for catalytic activity (65-66). Although these introns differ in size, they do fall into the range of 
160-500 nucleotides in length (3, 59, 65-66). The self-splicing reaction of group I introns (Figure 
2.9A) requires a guanosine cofactor, which is shown in the conserved guanosine-binding site. 
The 3’ OH of the guanosine attacks at the 5’ splice site, shown at the end of the P1 helix 
interaction, resulting in the addition of the guanosine to the 5’ end of the intron (G-addition 
reaction). Once the guanosine cofactor has effected the 5’ cleavage reaction, the conserved 
guanosine on the 3’ end of the intron (ωG) takes its place in the conserved guanosine-binding 
site (7, 36, 65). The 3’ OH of the 3’ terminal base on the 5’ exon is now free to attack at the 3’ 
splice site, on the 3’ end of the intron. This results in the ligation of the 5’ and 3’ exons and the 
excision of the intron. While some group I introns require proteins for this splicing in vivo, many 
can catalyze the reaction in vitro without proteins under physiological conditions (65).  
The self-splicing reaction for group II introns (Figure 2.9B) involves a conserved 
adenosine within domain 6 (D6) that attacks the 5’ splice site, identified by domain 1 (D1) (3, 
36, 65-66). This results in a lariat or loop intermediate. As with the exon ligation step of group I 
intron self-splicing, the terminal base of the 5’ exon attacks at the 3’ splice site; the exons are 
ligated and the lariat intermediate is excised.  This reaction bears similarities to the spliceosome-
mediated removal of introns mentioned previously. These introns also seem to require proteins 
for efficient in vivo splicing, even though they can splice without proteins in vitro. This in vitro 
splicing, however, occurs under extreme conditions (high metal ion concentration or low pH) 
and at a slower rate than the in vitro splicing of group I introns (65-66).  
 
2.4.2 Group I introns in detail 
Group I introns are found in genes for messenger, ribosomal, and transfer RNA in various 
species; they have not yet been reported in vertebrates (3). As previously stated, three molecular 
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interactions are involved in this self-splicing reaction, the P1, P9.0, and P10 helices, which are 
shown in Figure 2.10 (7, 33). Each of these helices is associated with a specific recognition 
element (RE) located in the intron; these recognition elements are sequences complementary to a 
region in the intron or the flanking exons. The formation of these helices serves to move the 
molecule into the conformation necessary for efficient splicing, as well as define splice sites (33, 
65). The aforementioned P1 helix involves base-pairing between RE1 (also termed the IGS or 
internal guide sequence) and the 5’ exon, while the P10 helix forms between the 3’ exon and 
RE3. The P9.0 helix forms intermolecularly between the RE2 region and the intron; this helix 
plays a role in defining the 3’ intron boundary and thus the 3’ splice site (33). There are two 
conserved and required components present in group I introns, the first being a conserved base-
pair formed between a guanosine in the intron (RE1) and a 3’ terminal uridine present in the 5’ 
exon. This base-pair denotes the first catalytic site (5’ splice site) and is found on the 3’ end of 
the P1 helix. The second component is ωG at the 3’ portion of the intron, defining the second 
catalytic site and marking the end of the intron, which immediately precedes the P10 helix (33, 
36, 65, 67).  
The self-splicing mechanism by which these introns operate is shown in more detail in 
Figure 2.10. Note that the exons are depicted as black lines and the intron is shown in gray.  The 
first step involves the cleaving of the 5’ exon from the transcript via nucleophilic attack by a 
required guanosine cofactor (7, 33, 36). The second step of exon ligation occurs through a 
second nucleophilic attack, this time by the 3’ OH of the terminal uridine (of the 5’ exon) on the 
3’ exon. This results in a new phosphodiester bond that links the 5’ and 3’ exons and the 
removed intron that has undergone the G-addition reaction (7, 33, 36).  
The conserved structure of group I introns contains various helical regions, as previously 
mentioned. Figure 2.11 shows the secondary structure of the group I intron from Pneumocystis 
carinii, with the intron sequences in uppercase letters and the exon sequences in lowercase letters 
(32).  As the structural elements are generally conserved in this category of catalytic RNA, this 
diagram serves as a general illustration of the structure of group I introns. The conserved 
nucleotides and interactions are found in the same general locations (36, 65). Two of these 
include the guanosine-binding site (in the P7 region) for the guanosine substrate and conserved 
adenosine residues that interact with the reaction site in the P1 helix (65, 67). Note also that the 
two catalytic sites are denoted with arrows; the terminal uridine of the 5’ exon and the ωG are 
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circled. As for the elements of the structure and the roles they play in the self-splicing reaction, a 
great deal of the current knowledge comes from studies of the Tetrahymena group I intron. The 
conserved A residues located above the P4 helix (shown boxed in Figure 11) interact with the 
conserved G•U base-pair in the P1 helix. The A•A mispair interacts with the conserved G•U 
base-pair through hydrogen-bonding (67-69). This is implicated in the 5’ splice site selection 
(67). As for 3’ splice site selection, ωG appears to play a major role (33, 67, 70-71). Please note 
that this conservation occurs in terms of location with respect to the helical regions.  
 
2.4.3 Trans-cleavage reaction 
 When the exons are removed from a transcript containing a group I intron, that remaining 
intron can, in turn, utilize the same molecular interactions to catalyze new reactions on 
exogenous substrates. This new construct, now referred to as a ribozyme, can be altered in terms 
of sequence-specificity to adapt to different targets (36, 72). The Tetrahymena intron is one of 
the most studied group I introns; one of the ribozymes derived from it catalyzes a trans-cleavage 
reaction (60, 73). The reaction, shown in Figure 2.12, requires a guanosine cofactor, as does the 
self-splicing reaction, and results in the cleaving of an exogenous substrate. The ribozyme is 
shown in gray and the substrate in black. The conserved G•U base-pair that defines the 5’ 
cleavage site is present in the P1 helix interaction that targets the substrate (60). Once the P1 
helix is formed, the 5’ cleavage site is attacked by the guanosine cofactor, leaving the substrate 
severed (60, 73). 
 This type of cleavage reaction using a group I intron-derived ribozyme has also been 
proposed as an option in gene inhibition, similar to the smaller ribozymes mentioned previously 
(60). This intron-derived ribozyme reaction has not been explored in this arena as readily as the 
hammerhead and hairpin ribozymes (31, 36, 60). This is partially attributed to the expected 
frequency of possible cleavage sites and the likelihood that the ribozyme would also destroy non-
targeted RNAs (60). Subsequent studies of group I introns, however, have led to additional 
ribozyme-catalyzed reactions with possible disease treatment capabilities (33-34). 
 
 2.4.4 Trans-splicing reaction 
The trans-splicing (TS) ribozyme is derived from the Tetrahymena group I intron (30, 
33). This ribozyme catalyzes a reaction that results in the replacement of the 3’ portion of an 
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RNA transcript and can occur in vitro and in vivo (30, 64, 74-75). The reaction can also be called 
ribozyme 3’ replacement splicing. A simple diagram of the reaction is shown in Figure 2.13; the 
molecular interactions previously mentioned play similar roles to the ones they play in the self-
splicing reaction. Note that the trans-splicing ribozyme carries a new 3’ exon on its 3’ end. The 
ribozyme is shown in gray, with the new 3’ exon depicted with an open line. The exogenous 
exon regions are shown in black. The P1 helix forms between the 5’ exon of the exogenous 
substrate and the RE1 region of the ribozyme; the P9.0 helix forms intramolecularly within the 
ribozyme, similar to what occurs in the self-splicing reaction (33). The 5’ cleavage reaction 
requires a guanosine cofactor, as does self-splicing. After the first step of 5’ cleavage, which 
leaves the 5’ exon of the exogenous substrate free, the P10 helix now forms between the new 3’ 
exon that is attached to the ribozyme and the RE3 region; notice that the 3’ exon from the 
exogenous substrate has undergone the G-addition reaction as the intron does in the self-splicing 
reaction (33). The second step of exon-ligation takes place much as it does in the self-splicing 
reaction, by way of a nucleophilic attack of the 3’ OH of the terminal uridine, located on the 5’ 
exon, on the new 3’ exon that is carried by the ribozyme. This results in a new RNA transcript, 
containing the original 5’ exon and a replacement 3’ exon (30, 33). This reaction gave new 
insight to catalytic RNA and spawned many further studies on its mechanism and requirements. 
In cases of mutations located on the 3’ end of an RNA transcript that are linked to disease or 
deficiencies that render the 3’ portion of a transcript defective (truncations or shortened 
transcripts, for example), this reaction provides a repair method for these transcripts, one that can 
be explored from a therapeutic standpoint. This reaction has been implemented in vivo as a 
correction method with sickle cell globin, the p53 transcript (heavily linked to cancer), and 
various other disease-linked genes (64, 74-75).  
 
2.4.5 Trans excision-splicing reaction 
Many studies have and continue to utilize the Tetrahymena group I intron and its derived 
ribozymes; however, various other group I introns have been discovered and investigated, as 
have the ribozymes derived from them (76-78). The Pneumocystis carinii group I intron, 
reported in 1989, can be found in the rRNA of this fungal entity (76). It is an opportunistic 
pathogen that commonly causes problems in immunocompromised patients (76). A ribozyme 
derived from its group I intron, however, has been reported to catalyze a novel reaction with 
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therapeutic possibilities (33). This reaction, termed trans-excision splicing (TES), is shown in 
Figure 2.14 and it results in the excision of 1 or more bases from an RNA substrate (33). Like the 
group I intron from which it is derived, it also utilizes the P1, P9.0, and P10 interactions in its 
catalysis. Just as in the previous diagrams, the exons are shown in black and the ribozyme in 
gray. The P1 helix forms between the RE1 in the ribozyme and the 5’ exon of the substrate; 
base-pairing between the RE3 region and the 3’ exon forms the P10 helix. P9.0 forms between 
RE2 and the bridge region of the substrate (33). The first step of the reaction, the 5’ cleavage, 
occurs via a nucleophilic attack from a free hydroxyl at the first catalytic site (after the 
aforementioned G•U base-pair). Note that this differs from the first step of trans-splicing in that 
no exogenous guanosine is required for the 5’ cleavage step. The second step of exon ligation 
transpires as previously described, through a nucleophilic attack by the 3’ OH of the terminal 
uridine on the 5’ exon. This leaves the excised bridge region and a new RNA (33). While this 
novel reaction also provides new information on ribozyme-catalyzed reactions, its therapeutic 
potential involves insertion mutations or repeat regions of nucleotides (in cases like Muscular 
Dystrophy) that are linked to disease (1, 3). 
 
2.4.6 Targets for group I intron-derived ribozyme reactions 
In terms of RNA repair or alteration, both the TS and TES reactions can cater to a variety 
of needs. Some cases of genetic mutations exist, however, in which neither of these methods 
present the most viable strategy. One case in particular involves the k-ras gene. This gene 
belongs to the ras family of genes that are involved in aspects of GTP-binding and activation in 
cellular processes (1, 79-81). The main three types of ras genes are n-ras, h-ras, and k-ras. 
Dysfunctional variants of each can be linked to different cancers, such as colorectal, pancreatic, 
and lung (79). The ras protein products are all approximately 188-189 amino acids in length and 
differences in sequence usually do not appear until after amino acid 85 (79, 81). The mutation 
hotspots in this gene are codons 12, 13, and 61 and usually contain substitution mutations, with 
codon 12 being most commonly reported (80). The native glycine (GGT/GGU) of codon 12 is 
required for the proper coding function of this transcript. Its mutation to any other amino acid or 
its deletion or insertions at that site prove detrimental to the resultant gene product (79-81). This 
mutation can be found in patients with certain types of cancer and the presence of the mutations 
in cells results in oncogenic (cancerous) transformation when studied in cell cultures (79-80). 
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While all three maintain a significant degree of homology in terms of sequence and size, their 
roles in living systems appear to be quite delineated (81). Investigations into the necessity of 
each of the forms of ras have presented evidence that k-ras bears a significant role in living 
organisms (81-83). Transgenic animals can survive gestation and function with minimal 
problems when the h-ras or n-ras genes are knocked out, or deleted (82). The deletion of the k-
ras gene, however, produces embryonic lethality in those animals; transgenic mice without k-ras 
do not survive past day 14 of gestation (81, 83). Thus, a functional k-ras transcript and protein 
product prove essential to animal systems. Dysfunctional k-ras transcripts, however, evidence 
themselves in 25-50% of lung cancer cases (84-85). 
In terms of possible RNA repair methods, the TES and TS reactions do not provide the 
most ideal strategies for correcting mutations in codon 12 of the k-ras gene. Since removal of the 
codon proves just as deleterious as a substitution mutation, trans-excision splicing cannot serve 
as a repair method. The location of the mutation, close to the 5’ end of the RNA transcript, 
renders ribozyme 3’ replacement splicing, or trans-splicing, a less than facile choice for 
correction. Therefore, the development of a novel ribozyme-catalyzed reaction that can replace 
the 5’ end of an RNA transcript would be a viable therapeutic option for the case of k-ras, as well 
as other disease-linked mutations, such as Huntington’s Disease (86). It would also lend new 
insight into reactions catalyzed by group I intron-derived ribozymes.  
By exploiting a 3’ recognition element (involved in P9.0 formation), to target the 
transcript substrate, a ribozyme was engineered that can effectively replace the 5’ end of a 
mutant RNA with a corrected version in a k-ras small model system. This reaction is termed the 
5’ replacement splicing (RS) reaction and a general diagram of it is shown in Figure 2.15; the 
ribozyme (derived from the P. carinii intron) is shown in gray with the new 5’ exon depicted as 
an open line. The exogenous exons are shown in black. The P1 and P10 helices form with the 
new 5’ exon and the 3’ exon of the exogenous substrate, respectively. P9.0 forms between the 5’ 
exon of the exogenous substrate and the RE2 of the ribozyme. The first step of 5’ cleavage 
occurs through a free hydroxyl and separates the new 5’ exon from the rest of the ribozyme. This 
differs from the TS reaction in that it does not need a guanosine cofactor for 5’ cleavage. The 
second step of exon ligation proceeds as it does in the self-splicing reaction. This study resulted 
in the first report of a ribozyme-catalyzed 5’ transcript replacement reaction, as well as the first 
ribozyme designed to utilize a 3’ recognition element (RE2) as the primary determinant of 
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substrate targeting. The reaction was probed in terms of the effect of length dependence of the 
P9.0 and P10 helices, and the L1 loop. This 5’ replacement splicing system was also compared 
with trans-splicing in terms of reaction rate and the effect of guanosine cofactors. These findings, 
as well as the full system design for the reaction will be fully discussed in this dissertation. 
 
2.5 Experimental methods used for nucleic acids 
2.5.1 Gel electrophoresis 
 The main method of analysis used in these studies is gel electrophoresis. Electrophoresis 
can be used to separate biomolecules (nucleic acids and proteins) on the basis of size; its medium 
is a gel matrix that can be agarose or polyacrylamide (3, 56). Theoretically, the molecules should 
move with respect to charge, size, and shape. With nucleic acids, charge and shape are 
consistent; thus size is the determining factor in migration. The molecules move courtesy of a 
constant electric field. These gels are “run” in this field vertically or horizontally. PAGE 
(polyacrylamide gel electropheresis) can be used with nucleotides when a difference in size 
down to single nucleotides needs to be seen. The gel is usually set between two glass plates and 
held there while it is run. The nucleic acid samples are applied to the gel at one end and migrate 
under the influence of the electric field (3, 56). Smaller molecules move faster and so move 
farther down the gel, while larger molecules remain higher up on the gel. One of the most 
common methods for visualizing and analyzing PAGE gels is autoradiography. 
 
2.5.2 Autoradiography 
 Autoradiography utilizes two components, radioactive specimens and photographic 
emulsions (56). The specimen is usually radiolabeled with radioisotopes such as 35S, 33P, and 32P, 
which emit β-particles as the unstable atoms decay (3, 56). The emulsions are suspensions of 
silver halide (AgCl, AgFl, AgBr, AgI) in gelatin. These emulsions usually undergo a process that 
places them on a thin surface, like X-ray film. After the radioactive specimens are fixed on a 
two-dimensional surface, the emulsion is exposed to it. Each β-particle emitted from the 
specimens converts some of the silver ions to silver atoms. This removes them from the crystal 
lattice of the emulsion. This creates an image, or a hole in the lattice corresponding to that area 
containing radioactive specimens (2-3, 56). The atoms of silver are likely to lose their electrons 
and return to the lattice, so the image is likely to fade. Thus, it must be developed before the 
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image is lost. The development process results in images or bands corresponding to the 
orientation of the specimens on the gel (56).  
 Traditional autoradiography requires X-ray film; however, the process of 
phosphorimaging provides an additional method of visualizing radioactive reactions. Plates, or 
screens, are coated with a light-responsive phosphor. The screen is exposed to the gel and the 
energy from the β-particles is stored in a europium-based coating (56). The screen is scanned by 
a laser and photons are released, and collected and used to form an image. This image is 
presented on a computer screen. This requires a more expensive instrument and specific software 
that can manipulate the image and allow for quantification of the bands. While more expensive 
than film, the time to acquire images is reduced 80-90% and a darkroom is not necessary (56). 
The images of PAGE gels shown in these studies have been acquired using this method.  
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Figure 2.1. DNA nucleotides. Each of the nucleotides contain a nitrogrenous base, which 
can be a purine or a pyrimidine, as well as a sugar (ribose) and a phosphate group. The 
nucleotides names and single-letter abbreviations, shown below each structure, 
corresponds with the identity of the purine or pyrimidine (which is located next to the 
base).  
 19
Figure 2.2. DNA structure. (A) A single strand or chain of DNA is shown. The 
nucleotides are linked through the phosphate group of one to the 3’ OH of another. The 
directionality of this linkage is termed 5’ to 3’. (B) A double strand or DNA duplex is 
depicted; the nucleotides interact through hydrogen-bonding between the purines and 
pyrimidines. This interaction is termed base-pairing; A pairs with T and C with G. Note 
that the strands are antiparallel, with one in the 5’ to 3’ direction and the other in the 
opposite 3’ to 5’ direction.  
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Figure 2.3. RNA structure. (A) The nucleotide uridine, which replaces 
thymidine in RNA, is shown. Note that in RNA, the 2’ position of the 
sugar has a hydroxyl group, whereas DNA has only a hydrogen at the 
corresponding position. (B) A common secondary structure for RNA is 
depicted as a line diagram, with a base-paired stem region and an unpaired 
loop region. 
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Transcription
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Transcription
Figure 2.4. Central dogma of molecular biology. The progression from DNA to 
RNA to protein is shown. The replication of DNA is synthesis; the DNA can be 
transcribed into RNA (RNA can also serve as a template for the reverse 
transcription of DNA). The RNA is then translated into protein. 
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Figure 2.5. Removal of introns via spliceosomal splicing. The exons are shown as 
black lines, while the intron is shown as a gray line. The spliceosome (a 
ribonucleoprotein construct), though not shown, mediates the splicing. In the first step, 
a conserved adenosine attacks the 5’ end of the intron, resulting in a lariat, or loop 
structure. The exons are ligated through the attack of the 3’ OH on the 3’ exon. The 
exons are joined, leaving begind the excised intron. 
mRNA transcript5’ 3’AExon 1 Intron Exon 2
OH
The conserved adenosine 
residue attacks at 5’ end of 
intron, creating a lariat 
structure.
5’ OH Intermediate
5’ 3’
Excised intron in 
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5’-GGTACGGCT-3’
3’-CCATGCCGA-5’
mRNA
tRNA
5’-GGUACGGCU-3’
3’-CCAUGCCGA-5’
Gly Thr   Ala 
Translation
Glycine-Threonine-Alanine
DNA
Transcription
Figure 2.6. Transcription and translation. A given sequence of double-stranded 
DNA is transcribed into mRNA (messenger RNA); this sequence contains 
sequences of three nucleotides that specify a particular amino acid. These 
sequences are also termed codons.  During translation, the codons in the 
mRNA pair with their respective complements, which are present in the tRNA 
(transfer RNA). The tRNA also has the amino acid that the codon codes for 
attached to it.  The ribosome (a ribonucleoprotein construct not shown) 
catalyzes the joining of the amino acids to give the resultant protein.   
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Figure 2.7. DNA ligation mechanism. The active lysine of this enzyme 
contributes an amine group, which acts as a nucleophile in the first step of 
enzyme adenylation. The cofactor, ATP, contributes AMP, which is joined to 
the enzyme and PPi is released. In the next step, this AMP is transferred to the 
donor oligonucleotide, thus forming an intermediate. The site of ligation 
shown between the donor and acceptor oligonucleotides is also termed the 
nick. In the last step, the donor and acceptor oligonucleotides are ligated 
together and AMP is released.  
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Figure 2.8. General secondary structures of and cleavage schemes for catalytic 
RNAs. The substrate sequences for each ribozyme are shown as dotted lines, 
while the sites of cleavage are specified with arrows. N denotes A, C, G, or U; D 
specifies A, C, or U. (A) RNase P (composed of proteins and RNA) cleavage (B) 
Hammerhead ribozyme cleavage (C) Hairpin ribozyme cleavage (D) Hepatitis 
delta virus cleavage.  
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Figure 2.9. Simple schematic of group I and II intron splicing. The exons are shown as 
dotted lines and the intron as a solid line. (A) The self-splicing reaction of group I introns 
requires a guanosine cofactor that is depicted in the conserved guanosine-binding site 
(GBS). This guanosine attacks at the 3’ end of the P1 helix and is added to the 5’ end of the 
intron (G-addition). The conserved guanosine on the 3’ end of the intron (ωG) moves into 
the GBS. The 3’ OH of the terminal base on the 3’ end of the 5’ exon attacks the 3’ exon, 
resulting in exon ligation and the excision of the intron. (B) The self-splicing reaction of 
group II introns entails a conserved A within domain 6 (D6). This adenosine attacks at the 
5’ splice site, (defined by domain 1, or D1), yielding a lariat intermediate. The second step 
of exon ligation proceeds as it does in group I intron self-splicing, with an attack from the 
terminal base of the 5’ exon on the 3’ exon.  
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Figure 2.10. Group I intron self-splicing diagram. The intron is depicted as a gray line, 
while the exons are black lines. P1, P9.0, and P10 are helices that result from the 
recognition elements RE1, RE2, and RE3 (respectively) of the intron base pairing with 
the exons and itself. P1 forms between RE1 and the 5’ exon, P10 forms between the 
RE3 and the 3’ exon, and P9.0 forms intramolecularly in the intron between the RE2 
and the 3’ intron. A conserved guanosine-uridine base-pair (located at the end of the P1 
helix) helps to define the first catalytic site, which is the 5’ splice site. This step of 5’ 
cleavage occurs via a nucleophilic attack by the required guanosine cofactor at the 5’ 
splice site and is shown in more detail on the right. The second step of exon ligation 
involves the conserved guanosine at the 3’ end of the intron, also termed ωG; this 
guanosine helps to define the 3’ splice site. The 3’ OH of the 3’ terminal uridine on the 
5’ exon attacks at the 3’ splice site, resulting in exon ligation and intron excision.  
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Figure 2.11. Secondary structure of Pneumocystis carinii group I intron. The 
sequence of the intron is shown in uppercase letters and that of the exons in 
lowercase. The uridine of the conserved guanosine-uridine base-pair and the ωG are 
circled, with the splice sites denoted with arrows. The guanosine-binding site is also 
noted.  
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Figure 2.12. Trans-cleaving reaction diagram. The catalytic RNA is 
represented by a gray line, the 5’ and 3’ regions are black lines. The black 
circle represents the uridine at the 5’ splice junction. This reaction also utilizes 
the P1 helix mentioned in the self-splicing reaction of group I introns. P1 
forms between RE1 and the 5’ portion of the substrate. A guanosine cofactor is 
required for the trans-cleavage. The reaction results in the substrate being 
cleaved at the 3’ end of the P1 helix and the ribozyme is left unchanged.  
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Figure 2.13. Trans-splicing or ribozyme 3’ replacement reaction diagram. The 
catalytic RNA  is represented by a gray line, the 5’ and 3’ exons are black lines, 
and the replacement exon carried by the ribozyme is represented by an open arrow. 
The black circle in the 5’ exon represents the uridine at the 5’ splice junction and 
the gray circle adjacent to the 3’ exon represents a guanosine at the 3’ splice 
junction. This reaction utilizes those same interactions and elements associated 
with the self-splicing reaction of group I introns. P1 forms between RE1 and the 5’ 
exon of the exogenous substrate and P9.0 forms within the intron, as it does in the 
self-splicing reaction. A guanosine cofactor is required for the first step of 5’ 
cleavage. The P10 helix then forms between RE3 and the new 3’ exon. Exon 
ligation preceeds as it does in the self-splicing reaction, resulting in the generation 
of a new RNA strand composed of the original 5’ exon and the new 3’ exon 
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Figure 2.14. Trans excision-splicing reaction diagram. The catalytic RNA is 
represented by gray lines, the 5’ and 3’ exons are black lines, and the bridge 
region to be excised is shown as a dotted line. The black circle in the 5’ exon 
represents the uridine at the 5’ splice junction and the gray circle adjacent to 
the 3’ exon represents a guanosine at the 3’ splice junction. This reaction 
utilizes the same interactions and elements associated with the self-splicing 
reaction of group I introns. P1 forms between RE1 and the 5’ exon, P10 
forms between the RE3 and the 3’ exon, and P9.0 forms between the RE2 
and the bridge region. The 5’ cleavage step does not require a guanosine 
cofactor; it utilizes a free hydroxyl in the nucleophilic attack. Exon ligation 
occurs as it does in the self-splicing reaction of group I introns.   
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Figure 2.15. 5’ Replacement splicing reaction diagram. The catalytic 
RNA is represented by gray lines, the 5’ and 3’ exons are black lines, 
and the replacement exon is represented by open arrows. The black 
circle in the 5’ exon represents the uridine at the 5’ splice junction and 
the gray circle adjacent to the 3’ exon represents a guanosine at the 3’ 
splice junction. This reaction utilizes those same interactions and 
elements associated with the self-splicing reaction of group I introns. 
P1 forms between RE1 and the new replacement 5’ exon, P9.0 forms 
between RE2 and the 5’ exon of the exogenous substrate, and P10 
forms between RE3 and the 3’ exon. The 5’ cleavage step does not 
require a guanosine cofactor; it utilizes a free hydroxyl in the 
nucleophilic attack. Exon ligation occurs as it does in the self-splicing 
reaction of group I introns.   
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Chapter 3 - Study of Canonical Bases as Universal Templates with T4 DNA Ligase  
 
3.1 Materials and Methods for the Universal Template Study 
3.1.1 Oligonucleotide Synthesis and Preparation 
 The oligonucleotides used were synthesized either on an Applied Biosystems 380B DNA 
Synthesizer or purchased from Integrated DNA Technologies (IDT, Coralville, IA). 
Oligonucleotides were purified either by reverse phase HPLC (IDT) or Thin Layer 
Chromatography, as described (31, 87-88) Designated oligonucleotides were 5' end radiolabeled 
by incubating 0.4 µM DNA, 0.43 µM [γ-32P] rATP (Amersham Pharmacia, Piscataway, NJ), 70 
mM Tris HCl (pH 7.5), 50 mM KCl, 10 mM MgCl2, 5 mM dithiothreitol, 0.1 mM EDTA, 0.1 
µM rATP, 10% glycerol, and 10 units of T4 polynucleotide kinase (New England Biolabs, 
Beverly, MA) in a reaction volume of 10 µL for 45 minutes at 37 ºC. The products were isolated 
and purified via a 17% native polyacrylamide gel, using 0.25x TBE as the running buffer (1x 
TBE is 100 mM Tris, 90 mM boric acid, and 1 mM EDTA at pH 8.4). The products were then 
isolated from the gel matrix via overnight pulverization in 2 mL sterile water with a stir bar, 
followed by centrifugation to partition the gel matrix from the solution. The radiolabeled product 
solutions were then evaporated to a final concentration of 8 nM. 
 
3.1.2 Ligation Reactions 
 All ligation reactions contained 3.1 pmol template, 2.5 pmol non-radiolabeled 
oligonucleotide (the acceptor molecule), 70 fmol radiolabeled oligonucleotide (the donor 
molecule), and 3 units T4 DNA ligase (Promega, Madison, WI.). In all ligation reactions the 
template and donor molecules were mixed in an appropriate buffer solution and denatured at 90 
ºC for 30 sec. After a 5 min annealing period at room temperature, the ligase and the acceptor 
molecules were added to the reaction mixture (10 µL total volume). This was then incubated for 
18 h at an appropriate temperature (listed in the figures and tables). The reactions were 
terminated by adding 7 µL stop buffer (10 mM urea, 0.1x TBE, 3 mM EDTA). Initial reactions 
were conducted in Promega’s standard recommended conditions, which consisted of 30 mM 
Tris-HCl (pH 7.8), 10 mM DTT, 10 mM MgCl2, and 1 mM rATP at 30 ºC. These conditions 
were subsequently optimized to test for universal templating abilities by altering the MgCl2 
concentration (varied from 1 mM to 100 mM), the ATP concentration (varied from 0.25 µM to 
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10 mM), time (varied from 1 hr to 24 h), temperature (varied from 4 ºC to 44 ºC), and by 
including additives such as dimethyl sulfoxide (DMSO; Malinckrodt), polyethylene glycol-8000 
(PEG; Sigma-Aldrich), and single-stranded binding protein (Promega; from 5% to 50%).  The 
final optimized buffer conditions were 30 mM Tris-HCl (pH 7.5), 10 mM DTT, 3 mM MgCl2, 10 
µM ATP, and 20% DMSO at either 30 ºC or 22 ºC for 18 h. In certain cases, 1 unit of calf 
intestinal alkaline phosphatase (CIAP; Promega) was added to individual reactions. Reaction 
products and intermediates were isolated using 11% denaturing polyacrylamide gels and the 
reactions were quantified using a STORM 860 Molecular Dynamics Phosphorimager. Observed 
rate constants were quantified by fitting the time-dependent data to a simple exponential 
function. 
 
3.1.3 Thermal denaturation experiments 
 Thermal denaturation experiments were run using a standard thermodynamic buffer [20 
mM sodium cacodylate, 1 M NaCl, and 0.5 mM Na2EDTA at pH 7.0] on a Beckman DU 650 
UV-VIS Spectrophotometer using a 15 µM total strand concentration (89-90). Measurements 
were taken using a wavelength of 260 nM.  
 
3.2 System Design 
 The test system for this project was designed to quantify ligation as a function of the 
sequences being ligated. In the diagram of the system shown in Figure 3.1, the oligonucleotides 
to be ligated are decamers that begin and end with the same nucleotide. Phosphorylated 
(represented by ‘p’) decamers are radiolabeled (represented by an asterisk) and are in italics. The 
names of the decamers to be ligated are represented by lowercase lettering according to what 
nucleoside (from 5’ to 3’) is paired with the universal template positions (in the grey box). The 
template names are in uppercase and represent the central universal template positions 
(underlined). On the left side, studies with the n position (at the actual nick) are shown. On the 
right, studies with the n-1 position (adjacent to the nick) are illustrated. The acceptor molecules 
contain a 3’ OH group and the donor molecules contain a radiolabeled 5’ phosphate. Once the 
decamers bind to a template, T4 DNA ligase catalyzes the formation of a covalent bond between 
the 5’ phosphate and 3’ OH group (See Figure 2.7 and Example in Figure 3.1). By having only 
one decamer that can act as a donor molecule and using an excess of the acceptor molecule 
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(which contained only hydroxyl groups on both ends), the sequence of oligonucleotides being 
ligated was controlled. Template oligonucleotides possessed a centrally located region with of a 
single type of nucleoside in tandem, which flanked the ligation junction when paired to the donor 
and acceptor molecules. Thus, ligation was analyzed as a funtion of template sequence. All 
oligonucleotides are written in the 5’ to 3’ direction, save when denoted otherwise. In this report, 
the focus was on the sequences at the ligation junction and the n-1 positions.   
 
3.3 Results 
3.3.1 Investigation of the n Position - Standard Conditions 
 All 16 dinucleotide n position combinations were explored with 4 different templates; 
these templates had either A, C, T, or G as the template nucleosides at the site of ligation. For 
this, T4 DNA ligase (Promega) was used under the standard manufacturer’s conditions. A ratio 
of 1/0.8/0.02 template, non-radiolabeled acceptor, and radiolabeled donor, respectively, gave the 
best results (data not shown). A representative gel, using the T2 template is shown in Figure 3.2. 
The standard reaction conditions were 30 mM Tris-HCl (pH 7.5), 10 mM DTT, 10 mM MgCl2, 1 
mM ATP, 2.5 pmol acceptor molecule, 70 fmol donor molecule, 3.125 pmol T2 template, and 3 
units T4 DNA ligase at 30 ºC for 18 h. P represents product, I denotes adenylated intermediate, 
and S represents starting material; these designations are located on the right side of the gel. The 
reaction components are shown above each lane. The first lane contains a generic 25 base size 
control, the next four lanes are the four unreacted donor molecules, and the next two lanes are 
the synthetic (a + pa) and (c + pa) size controls. The next four panels show the 16 possible 
reactions. The next three lanes show control assays with the ligation of (a + pa) without template, 
with template and treated with calf alkaline intestinal phosphatase (CIAP) after the reaction has 
gone to completion, and without ligase. All experimental indications inferred that these assays 
used were functioning properly, evidenced by the number and size of the products. The ligation 
of (c + pa) yielded an intriguing product. The product ran noticeably lower than the other ligation 
products, as shown in Figure 3.2. This trend also occurred with each of the four templates (data 
not shown). A synthetic size control of the (c + pa) product was run on the gel and also migrated 
faster than other products. Apparently, this specific sequence exhibited atypical behavior in 
terms of its migration. Observe that the (a + pa) and (c + pa) size controls ran marginally faster 
than the actual ligation products, which was attributed to the presence of 5’ phosphates in the 
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controls that were absent in the actual ligation products. Further indications that the assays were 
working correctly were evidenced by the results of the control assays. The formation of both 
products and intermediates happened in a template-dependent manner. Moreover, 
dephosphorylation of the product band did not produce any notable reduction in intensity. This 
would be expected if the product was only internally radiolabeled. In other words, two 
radiolabeled donor molecules were not being ligated together.  
Table 3.1 lists the results of duplicate trials with standard deviations using each of the 
four templates. The data shows percent product formation (in bold) and percent intermediate 
formation (in parenthesis). The horizontal heading denotes template used and vertical heading 
denotes the new ligated product. Refer to Figure 3.1 for designations of acceptor, donor, and 
template oligonucleotides. When complete complementarity occurred in the duplex, the ligation 
extent was 95% or more, which was anticipated. When one mismatch occurred between the 
universal template region and the ligation junction, most ligations resulted in greater than 80% 
product (the few exceptions still reacted over 45%). When no complementary base pairing 
occurred at the ligation junction, the results varied widely; some dinucleotide combinations were 
ineffective (for example, 11% for (a-pc)/A2), while some were quite effective (for example, 77% 
for (c-pa)/A2). Each of the canonical nucleosides displayed at least some ability to template the 
ligation of all 16 dinucleotide combinations. When judged by the average product generated as a 
function of template, the effectiveness of each template reacting with each of the 16 possible 
sequence combinations followed the order G2 (63%) ≅ T2 (62%) > A2 (58%) > C2 (47%).  
 
3.3.2 Investigation of the n Position - Optimized Conditions 
The previous results illustrated that T4 DNA ligase is a sequence-dependent enzyme 
when used under its standard conditions. In cases of low product formation, however, adenylated 
intermediate formation was usually substantial. For product formation to increase, only the 
second step of the reaction had to be boosted (the ligation step in Figure 3.1). Changes in three 
components of the reaction resulted in augmented product formation. The optimization data is 
shown in Figure 3.3; product is represented by squares and intermediate by circles. As evidenced 
in panel A, the optimum concentration of 3 mM MgCl2 was found using the previously 
mentioned reaction conditions. Subsequently, it was implemented in the ATP-dependent assay in 
panel B. Both of these factors were optimized using (c+pc)/T2 as a test reaction. The data from 
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these assays showed that the optimized MgCl2 and ATP concentrations enhanced product 
formation of (c + pc)/T2 from 12% (Table 3.1) to greater than 90%. Another ligation reaction 
with low product formation, (c + pc)/C2, was also tested with the optimal MgCl2 and ATP 
concentrations. Yet, (c + pc)/C2 ligated no better using these conditions (data not shown). 
Additives to the reaction were then evaluated for their effect in improving product formation. 
DMSO was tested using 3 mM MgCl2 and 10 µM ATP and its inclusion in the reaction (c+pc)/C2 
improves the ligation from less than 10% to greater than 90% (Figure 3.3C). PEG, a molecular 
crowding agent, was also considered, but was not found to be beneficial. The addition of SSB 
also had no beneficial effect on the reaction (data not shown). Time-dependence assays were run 
using (c+pc)/T2 in 3 mM MgCl2, 10 µM ATP, and 20% (w/v) DMSO. Figure 3.3D shows this 
time-dependence plot of the reaction. This did indicate that no product breakdown transpired 
over time.  
Figure 3.4 shows a representative gel under the final optimized conditions with the T2 
template; the optimum reaction conditions were 30 mM Tris-HCl (pH 7.5), 10 mM DTT, 3 mM 
MgCl2, 10 µM ATP, 20% DMSO (w/v), 2.5 pmol acceptor molecule, 70 fmol donor molecule, 
3.125 pmol T2 template, and 3 units T4 DNA ligase at 30 ºC for 18 h. The same designations 
used in labeling the reactions and bands in Figure 3.2 were also used in Figure 3.4. Table 3.2 
shows the results of duplicate trials and the standard deviation values of all 64 combinations of 
decamers and template under the optimized conditions. The horizontal and vertical heading 
designations for Table 3.1 are also used here. The percent of product formed is shown in bold, 
while the percent of intermediate formed is in parenthesis. These optimized conditions 
considerably augmented the ligation of mismatched nucleosides at the site of ligation. Moreover, 
they did not decrease the effectiveness of ligation with matched base pairs. The average for the 
16 dinucleotide combinations with each template is T2 (97%) ≅ G2 (96%) > A2 (93%) ≅ C2 
(92%). Under these optimized conditions, all four of the canonical nucleosides directed the 
effective ligation of all 16 possible sequence combinations at the n positions. A-T pairs at the n-1 
positions were also tested for effective ligation and were not found to hinder the ligation extent 
(data not shown). Therefore, C-G pairs were not required for successful ligation. 
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3.3.3 Investigation of the n-1 Position – Optimized Conditions  
The next step in analysis focused on whether these optimal experimental conditions could 
allow ligation of decamers that are mismatched at the positions adjacent to the ligation junction 
(the n-1 positions in Figure 3.1) when the n position was base paired. For this investigation, the 
templates contained a central tandem segment of 4 identical nucleosides. The results, displayed 
in Table 3.3 in duplicate, showed that these optimized experimental conditions did encourage 
effective ligation when mismatches at positions adjacent to the ligation junction were present. 
The percent product formation and percent intermediate formation are shown as in previous 
tables, along with the standard deviations. The horizontal and vertical headings again denote 
template used and the new ligated product, respectively. The x shown in the vertical heading is 
defined in the horizontal heading.  Refer to Figure 3.1 for naming designations. Nearly all 
combinations worked well, but 4 out of 64 yielded less than 50% product. Lowering the reaction 
temperature from 30 ºC to 22 ºC (denoted with ♦ in Table 3.1), in these instances significantly 
improved these reactions. The reaction (gt-pta)/A4 went from 6.2% to 83.1%, (gt-ptc)/A4 went 
from 24.6% to 87.2%, (cg-pgc)/C4 went from 34.7% to 90.9%, and (tg-pgc)/C4 went from 42.2% 
to 97.4%. This drop in the reaction temperature conceivably benefited the hybridization of the 
decamers to the template and was not presumed to appreciably hamper the other reactions. The 
effectiveness of the template nucleosides was similar to what is seen in the n position; T4 (92%) 
≅ G4 (92%) > A4 (80%) ≅ C4 (79%).  
 
3.3.4 Investigation of Mismatches at Both the n and n-1 Positions 
Mismatches at both the n and n-1 positions (either in the donor molecule, the acceptor 
molecule, or both) underwent scrutinization. Analyzing all 256 possibilities (using a 
homogeneous universal template region) was not feasible, so a subset of 16 representative 
sequence combinations for each template served as general test reactions (Table 3.4). For this 
system the reaction temperature was 22 ºC, as it appeared to work better than 30 ºC in cases of 
low product formation and was assumed to be a good initial temperature for a double mismatch 
study. 
When no mismatches occurred (dark gray background in Table 3.4), the extent of ligation 
was 89%-96%, as anticipated. The same designations used in previous tables are also used in 
Table 3.4; the results from duplicate trials are shown with the standard deviation values. When 2 
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successive mismatches occurred either with the donor and template or the acceptor and template 
(light gray background), ligation generally proceeded well (5% to 97%), except for (gg-pcc)/C4 
(31%). In cases of mismatches at all four positions, the extents of reaction varied widely. Using 
the A4, C4, and G4 templates, some donor-acceptor combinations yielded low amounts of 
product, less than 3% ligation product. With the T4 template, however, substantial ligation for all 
sequence combinations occurred. Reaction temperatures lower than 22 ºC did not boost product 
formation in these reactions further. Decreased ligation effectiveness as the number of 
mismatches increased was not unexpected, as each mismatch probably contributed to helix 
destabilization and cases “fraying” at the ends of the duplexes. Regardless, these results showed 
that up to four consecutive mismatches flanking the ligation junction can be effectively ligated.  
In these assays, mismatches and/or overhangs occurred at the termini not being ligated 
(refer to Figure 3.1). To ascertain whether or not this was a factor in the reactions, systems that 
mimic (ta-pat)/T4 and (tt-ptt)/T4, except that the non-ligating terminal ends of each substrate 
were shortened and were completely complementary with the template were examined. The non-
ligating terminal mismatches did not significantly affect our results, as the extent of ligation for 
(ta-pat)/T4 went from 95.6% in the end-matched system to 96.8% in the end-mismatched system. 
The reaction (tt-ptt)/T4 went from 24% in the end-matched system to 29.4% in the end-
mismatched system. This provided evidence that the presence of terminal mismatches does not 
play an obvious role in the experimental results.  
 
3.4 Time Studies and Melting Curves 
The ligation reactions in this report were quantified at 18 h, but it was supposed that the 
rates of ligation varied from one combination to another. Substrate-template combinations that 
were more complementary were presumed to possess higher rate constants. Confirmations of this 
trend were obtained via time-dependent ligation assays run at 22 ºC using the representative 
systems shown in Figure 3.5. The data points shown are from two independently run assays with 
standard deviation values under 10%. The completely matched system, (gg-pgg)/C4, reacted 
swiftly, with ligation being complete within 1 min. The duplex (tt-ptt)/C4, reacted the slowest, 
probably as a result of its four mismatches.  Complete ligation was obtained in approximately 12 
h. The two systems that possessed intermediate observed rate constants both had mismatches at 
the n-1 positions. Refer to Table 3.3 and the ligation of (cg-pgc)/C4 and (tg-pgt)/C4, respectively.  
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The first reaction displayed unsuccessful ligation at 30 ºC and was more than 10-fold slower at 
22 ºC than (tg-pgt)/C4, which ligated well at 30 ºC. No product breakdown during the reactions 
indicated that 18 h appeared to be an acceptable endpoint for these representative systems, which 
provided another important fact about the reaction. 
In addition, melting curves were obtained for the duplexes used in the time studies via 
thermal denaturation experiments using a standard thermodynamic buffer and shown in Table 
3.5. A standard buffer was used because attempts to determine thermal stabilities of the various 
pre-ligated duplexes under our reaction conditions were unsuccessful due to fact that the melting 
curves did not show a sigmoidal structural transition. The values reported were the average of 
two independent assays. As could be expected, the duplexes that had higher rate constants also 
possessed higher melting temperatures (Tm) than those duplexes that ligated slower.  
 
3.5 Discussion 
 This report imparts new information about T4 DNA ligase and its ability to ligate 
oligonucleotides irrespective of the sequence of the terminal ends of the oligonucleotides being 
joined. Mismatches only at the n position resulted in no less than 80% of ligation product 
formed. Mismatches at the n-1 position yielded no less than 50% ligation product (following 
final temperature optimization). Though instances with 2 or more mismatches at the ligation 
junction generated product formation above 50%, the extent of ligation was inversely 
proportional to the number of mismatches.  
 
3.5.1 Reaction Conditions 
 The optimization experiments demonstrated that the fidelity of T4 DNA ligase began to 
lower in a relatively narrow range of MgCl2 concentration (between 2 and 4 mM, Figure 3.2A). 
Though the reason for such a narrow range was not known, it was not suspected to be attributed 
to the inactivity of the ligase at higher MgCl2 concentrations, as intermediate was steadily 
formed up to 10 mM MgCl2. Moreover, since the formation of intermediate depended on the 
formation of the duplex (Figure 3.5), this effect, in turn, did not appear to be due to the presence 
or absence of duplex formation at higher MgCl2 concentration. It could, however, have related to 
how stable the helix was once formed. It has been previously noted that ligation of mismatches 
occurred most effectively when the Tm of the pre-ligated duplex was slightly below the reaction 
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temperature, and that only transient in-line attack was required for ligation (12, 25). Perhaps only 
the narrow range of divalent cation permitted these steric conditions to occur. If so, then ligating 
molecules that form less secure duplexes may have required the adjustment of the MgCl2 
concentration.  
The optimal range of ATP concentration was 10 to 100 µM. Too little of this cofactor 
proves ineffective as it does not allow for sufficient binding of ATP to the enzyme (91), leading 
to a lack of enzyme adenylation (Step 1 of Figure 2.7). At high levels of ATP, intermediate 
formation was established, which indicated enzyme activity and the formation of the DNA 
duplex. Product formation was low, however, in these cases. Conceivably, the enzyme is 
consistently adenylated at high concentrations of ATP. Once the adenylated enzyme transfers the 
AMP to the donor molecule, the enzyme can then separate from the complex. If re-adenylation 
occurs the before the enzyme rebinds to the adenylated intermediate, it cannot catalyze the final 
ligation step.  
The supplementation of the reaction with 10% to 30% DMSO greatly benefited the 
ligation of some mismatched oligonucleotides, mainly through an increase in the ligation step of 
the reaction. Perhaps, then, nucleoside analogues developed to behave as universal bases may 
show an increase in ligation function when DMSO is incorporated into the reaction. While the 
origin of the DMSO effect was unknown, it has been reported that DMSO can diminish the 
specificity of nucleoside-binding restriction enzymes (51-52). The results of this study echoed 
those reports. This effect is termed star site activity. On the other hand, DMSO might not have 
acted directly on the protein, since ligation of fully base paired nicks did not occur any faster in 
the presence or absence of DMSO (data not shown). DMSO may have been interacting with the 
DNA backbone in a manner that was favorable to the orientation of the mismatched components 
for the reaction.  
The effectiveness of the ligation reactions at 30 ºC for the single and double mismatches 
and 22 ºC for the quadruple mismatches showed that the drop in temperature permitted more 
effective hybridization of the oligonucleotides to the template. Dropping the temperature even 
further proved ineffective, in all probability because the duplex increased in rigidity or the 
enzyme activity decreased. Higher ligation temperatures also did not help, because the resultant 
drop in hybridization strength would have been expected to increase the fidelity of the ligation 
reaction (42, 92). Useable melting curves were obtained using a standard thermodynamic 
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analysis buffer (Table 3.5). For the pre-ligated representative duplex systems shown in Figure 
3.5, those systems that ligated most effectively in general had the highest melting temperatures. 
Those systems appeared to be more stable (with respect to hybridization) and more effective in 
terms of reactivity, which suggested that hybridization strength played an important role in 
reactivity.   
 
3.5.2 Canonical Nucleosides as Universal Template Bases 
All of the four canonical nucleosides acted as universal template bases at both of the n 
positions or both of the n-1 positions. This also occurred when mismatches were present in either 
the donor or the acceptor (Table 3.4, light gray boxes). These mismatches in the donor molecule 
when the template was C4 were less effective than other double mismatch combinations. When 
mismatches occurred at all 4 positions, however, ligation efficiencies decreased notably.  
A straightforward association between the predicted thermodynamics of the individual 
mismatches (92-97) and the effectiveness of ligating oligonucleotides that contain such 
mismatches (at the ligation junction) did not appear to exist. With one or two mismatches, all 
types of mismatches worked well under the optimized conditions, regardless of whether the 
individual mismatches were predicted to be stable or structured. When four mismatches occurred 
and were expected to be stable, only (gg-pgg)/G4 and (tt-ptt)/G4 ligated well, whereas (aa-
paa)/G4 and (gg-pgg)/T4 did not. When four mismatches occurred and were expected to be 
unstable, (tt-ptt)/C4 and (cc-pcc)/T4 worked well, whereas (cc-pcc)/C4 did not. Thus, the presence 
of structure at these positions was not a factor in determining ligase activity, or the different 
reaction conditions utilized between these reports prohibited a direct comparison of the results.  
In general, sequence-independent ligation occurred using any of the canonical 
nucleosides in the template flanking the n position. These template nucleosides may or may not 
have formed hydrogen bonds with the corresponding nucleosides in the donor or the acceptor 
molecule. It may be that the lack of any specific and required interactions permitted the 
sequence-independent ligase activity that was observed. Previous reports show that T4 DNA 
ligase can ligate oligonucleotides even if there is a single nucleotide gap or a residue that is 
missing a purine or pyrimidine (19) at the ligation junction. When considered alongside the 
above data, it appears that the requirements for T4 DNA ligase do not include stable base pairing 
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at the site of ligation. As suggested previously (25), transient proximity is expected to be 
sufficient.  
As a template nucleobase, thymidine consistently performed as well as or better than the 
other nucleobases. This was underscored by the fact that the G4 template directed the ligation of 
tt to ptt poorly (5%) as compared with the T4 template directing the ligation of gg to pgg (87%). 
There was no hint that guanosines ligate together more effectively than thymidines. Thymidine 
must have participated in a distinctive role, but only in the template positions, and not when it 
was in the donor and acceptor terminal positions. Pyrimidines did not appear to perform better in 
template positions, since cytidine was the poorest universal template base. The low tendency of 
thymidine to form rigid structures combined with its relatively small size may have given it the 
flexibility to permit the corresponding nucleobases in the opposite strand to adopt a transitory 
conformation for reactivity. Since most mismatches are expected to be destabilizing, however, 
the number of canonical universal template bases that a given template can include will likely be 
restricted. 
 
3.6 Comparison with Previous Reports 
 The general idea throughout the literature is that mismatches, when tolerated, are more 
permissible at the terminal donor position than the terminal acceptor position (13-14, 20, 22-24, 
26). With our experimental conditions, this effect was not evident with n or n-1 mismatches, 
because mismatches appeared to ligate similarly. 
  Although enzymatic methods were used here for analyzing low fidelity ligation 
reactions, evidence shows that chemical ligation methods (37-39) can be utilized to ligate 
oligonucleotides that contain mismatches (38-42). One advantage to using chemical methods is a 
faster rate of ligation than that of enzymatic methods. Furthermore, chemical methods can be 
effective at lower temperatures (down to 0 ºC). This permits more effective oligonucleotide 
hybridization. Enzymes, on the other hand, are largely inactive at lower temperatures. In the case 
of a single mismatch at the ligation junction, the efficiency of chemical ligations drops, while the 
fidelity appears to be relatively high in comparison with the results presented here (38, 40, 42). 
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3.7 Implications 
 The results presented in this study should advocate caution when performing experiments 
that rely on the exclusive ligation of matched pairs using T4 DNA ligase. As shown here, its 
fidelity can be lowered fairly easily. Low fidelity conditions consisted of relatively low amounts 
of MgCl2 (3 mM) and ATP (10-100 µM). The addition of 10-30% DMSO (w/v) enhances this 
effect.  
Bear in mind that while low fidelity can be shown in vitro, such results are not 
anticipated in vivo. This directly relates to the importance of the genomic processes of 
recombination, replication, and repair, since a low fidelity ligase would result in high mutagenic 
rates in vivo and a loss in genome integrity. 
 Canonical nucleosides can serve as universal bases in ligation templates, at least at and 
adjacent to ligation junctions. This could lead to new procedures that permit the ligation of 
oligonucleotides with unspecified or degenerate terminal ends. A template molecule with 
thymidines in succession at the ligation junction could order the ligation of various 
oligonucleotides. When the sequence of the substrate region flanking the ligation junction is 
identified, simple PCR reactions can be used to amplify ligated products for their subsequent 
sequencing. In its most straightforward form, this strategy, along with similar methods, could be 
useful for sequencing the terminal ends of oligonucleotides. 
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Table 3.1 Results of n position investigation 
under standard conditions.  
 A2 C2 G2 T2 
a-pa 12.8 ± 1.1 (72.8 ± 0.6 ) 
42.1 ± 2.5 
(51.0 ± 0.5) 
12.8 ± 2.8 
(31.4 ± 3.0) 
97.3 ± 0.6 
(1.6 ± 0.1) 
c-pa 76.9 ± 0.5 (14.2 ± 5.1) 
9.1 ± 2.2 
(70.6 ± 2.9) 
81.7 ± 6.8 
(6.9 ± 0.1) 
45.9 ± 8.3 
(47.9 ± 11.2) 
g-pa 17.5 ± 0.4 (27.2 ± 0.3) 
83.0 ± 5.9 
(9.1 ± 2.1) 
6.5 ± 0.9 
(42.5 ± 2.3) 
96.6 ± 0.1 
(2.3 ± 0.1) 
t-pa 86.8 ± 2.1 (7.7 ± 1.8) 
29.4 ± 4.0 
(64.0 ± 0.5) 
84.9 ± 1.4 
(11.1 ± 2.3) 
97.4 ± 0.7 
(1.5 ± 0.5) 
a-pc 11.4 ± 3.0 (65.7 ±14.8) 
23.9 ± 4.3 
(70.3 ± 5.1) 
88.1 ± 0.2 
(11.1 ± 0.2) 
92.3 ± 2.9 
(5.1 ± 2.1) 
c-pc 72.9 ± 1.4 (23.9 ± 0.7) 
8.1 ± 1.4 
(28.7 ± 0.2) 
98.3 ± 0.1 
(1.3 ± 0.1) 
11.8 ± 4.6 
(65.1 ± 1.1) 
g-pc 27.4 ± 1.1 (18.7 ± 1.0) 
56.1 ± 7.8 
(38.0 ± 9.1) 
97.1 ± 0.3 
(2.2 ± 0.2) 
6.8 ± 0.4 
(73.4 ± 2.4) 
t-pc 95.3 ± 2.0 (2.2 ± 0.6) 
25.5 ± 0.4 
(65.7 ± 8.8) 
92.0 ± 2.3 
(4.3 ± 2.4) 
38.8 ± 1.8 
(48.9 ± 0.1) 
a-pg 9.1 ± 0.1 (63.1 ±10.0) 
86.2 ± 12.8 
(6.4 ± 3.1) 
21.1 ± 7.3 
(33.7 ± 3.6) 
94.4 ± 0.3 
(4.1 ± 0.4) 
c-pg 73.4 ± 1.9 (23.9 ± 1.1) 
47.9 ± 2.6 
(43.7 ± 3.1) 
78.8 ± 6.9 
(12.8 ± 3.8) 
32.1 ± 1.8 
(58.7 ± 1.0) 
g-pg 25.4 ± 0.1 (20.9 ± 0.3) 
94.7 ± 1.2 
(1.7 ± 0.1) 
10.5 ± 5.7 
(47.2 ± 3.5) 
55.2 ± 3.9 
(36.6 ± 6.7) 
t-pg 94.7 ± 2.4 (2.8 ± 0.6) 
93.1 ± 3.9 
(4.7 ± 2.0) 
49.1 ± 8.8 
(16.4 ± 3.8) 
86.8 ± 4.7 
(7.9 ± 2.6) 
a-pt 76.9 ± 7.0 (21.7 ± 6.6) 
45.4 ± 3.3 
(46.0 ± 0.3) 
38.2 ± 1.9 
(48.5 ± 5.6) 
92.1 ± 0.2 
(5.1 ± 0.4) 
c-pt 97.5 ± 0.1 (1.5 ± 0.1) 
7.2 ± 5.3 
(32.6 ± 10.8) 
95.0 ± 0.1 
(3.5 ± 0.2) 
18.6 ± 1.1 
(75.1 ± 0.6) 
g-pt 53.1 ± 2.3 (41.3 ± 2.7) 
80.1 ± 0.8 
(12.1 ± 7.5) 
53.3 ± 3.6 
(43.1 ± 3.6) 
34.5 ± 0.7 
(52.3 ± 4.6) 
t-pt 97.8 ± 1.1 (1.5 ± 0.9) 
15.8 ± 6.1 
(69.6 ± 7.8) 
87.7 ± 7.8 
(4.9 ± 2.3) 
85.2 ± 2.2 
(11.4 ± 1.1) 
Average 58.1 ± 34.8 (25.6 ± 23.5) 
46.7 ± 32.1 
(38.4 ± 25.6) 
62.2 ± 34.0   
(20.1 ± 17.1) 
61.6 ± 34.3 
(31.1 ± 28.6) 
The horizontal headings denote the template used, while the 
vertical labels refer to the newly ligated product. The percent 
of product formed is shown in bold, with the amount of 
intermediate shown in parenthesis. Both values are shown 
with standard deviations. The averages for each template are 
also shown in the same format. The reactions were run with 
30 mM Tris-HCl (pH 7.5), 10 mM DTT, 10 mM MgCl2, 1 
mM ATP, 2.5 pmol acceptor molecule, 70 fmol donor 
molecule, 3.1 pmol T2 template, and 3 units T4 DNA ligase 
at 30 ºC for 18 h. 
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Table 3.2 Results of n position investigation 
under optimized conditions.  
 A2 C2 G2 T2 
a-pa 96.2 ± 2.7 (1.4 ± 1.0) 
97.0 ± 0.3 
(1.5 ± 0.1) 
95.5 ± 1.2 
(1.4 ± 1.0) 
97.8 ± 0.6 
(0.6 ± 0.1) 
c-pa 95.9 ± 1.9 (1.4 ± 0.6) 
94.4 ± 0.8 
(2.9 ± 0.5) 
91.8 ± 6.1 
(1.7 ± 0.1) 
95.9 ± 2.2 
(0.6 ± 0.1) 
g-pa 93.4 ± 5.0 (1.5 ± 0.5) 
96.0 ± 1.4 
(2.0 ± 0.8) 
96.5 ± 1.8 
(1.3 ± 0.8) 
98.5 ± 0.1 
(0.3 ± 0.1) 
t-pa 93.5 ± 6.2 (1.3 ± 0.8) 
96.9 ± 6.2 
(1.5 ± 0.7) 
97.5 ± 1.6 
(0.9 ± 0.7) 
98.5 ± 0.3 
(0.3 ± 0.1) 
a-pc 97.3 ± 0.2 (1.3 ± 0.2) 
92.2 ± 6.5 
(4.5 ± 3.6) 
94.0 ± 7.1 
(2.4 ± 2.8) 
97.8 ± 0.3 
(0.8 ± 0.4) 
c-pc 85.7 ± 4.5 (5.7 ± 1.6) 
95.0 ± 2.4 
(2.9 ± 1.8) 
97.1 ± 0.6 
(1.6 ± 0.4) 
97.7 ± 0.9 
(0.6 ± 0.1) 
g-pc 86.1 ± 2.0 (6.3 ± 0.1) 
86.4 ± 1.6 
(9.2 ± 4.2) 
92.8 ± 7.6 
(3.2 ± 3.1) 
98.4 ± 0.2 
(0.5 ± 0.1) 
t-pc 97.2 ± 1.0 (1.7 ± 0.7) 
88.0 ± 1.0 
(7.7 ± 2.8) 
97.9 ± 0.9 
(1.1 ± 0.6) 
98.5 ± 0.1 
(0.4 ± 0.1) 
a-pg 91.7 ± 3.5 (1.8 ± 0.1) 
90.0 ± 3.5 
(7.4 ± 7.0) 
93.1 ± 2.2 
(1.5 ± 0.9) 
95.4 ± 0.2 
(0.5 ± 0.1) 
c-pg 90.8 ± 0.7 (1.9 ± 0.1) 
95.4 ± 0.7 
(2.1 ± 0.5) 
95.4 ± 0.7 
(1.8 ± 0.1) 
92.2 ± 0.4 
(0.8 ± 0.2) 
g-pg 88.3 ± 1.6 (1.9 ± 0.1) 
94.3 ± 3.2 
(2.6 ± 0.6) 
92.5 ± 0.8 
(2.4 ± 0.1) 
93.4 ± 3.0 
(2.8 ± 3.0) 
t-pg 92.9 ± 1.4 (1.9 ± 0.2) 
95.1 ± 4.1 
(2.3 ± 0.8) 
94.1 ± 1.3 
(2.4 ± 0.3) 
94.7 ± 2.4 
(0.6 ± 0.3) 
a-pt 97.7 ± 0.1 (1.3 ± 0.3) 
85.3 ± 0.5 
(8.2 ± 1.3) 
96.7 ± 5.3 
(1.6 ± 0.6) 
97.6 ± 0.7 
(1.1 ± 0.1) 
c-pt 89.6 ± 0.1 (0.8 ± 0.1) 
80.2 ± 0.3 
(16.8 ± 3.0) 
98.1 ± 2.6 
(0.8 ± 0.1) 
97.6 ± 0.2 
(1.1 ± 0.5) 
g-pt 94.6 ± 0.6 (2.8 ± 1.6) 
96.2 ± 0.1 
(1.8 ± 0.2) 
97.6 ± 0.3 
(1.1 ± 0.1) 
97.8 ± 0.2 
(1.3 ± 1.0) 
t-pt 89.5 ± 0.3 (5.8 ± 4.1) 
96.5 ± 5.8 
(1.7 ± 0.1) 
97.7 ± 0.3 
(1.0 ± 0.2) 
97.8 ± 0.7 
(1.4 ± 0.8) 
Average 92.5 ± 3.9 (2.4 ± 1.8) 
92.4 ± 5.0 
(4.7 ± 4.2) 
95.5 ± 2.2 
(1.6 ± 0.7) 
96.9 ± 2.0 
(0.9 ± 0.6) 
The horizontal headings denote the template used, while the 
vertical labels refer to the newly ligated product. The percent 
of product formed is shown in bold, with the amount of 
intermediate shown in parenthesis. Both values are shown with 
standard deviations. The averages for each template are also 
shown in the same format. The reactions were run with 30 mM 
Tris-HCl (pH 7.5), 10 mM DTT, 3 mM MgCl2, 10 µM ATP, 
20% DMSO, 2.5 pmol acceptor molecule, 70 fmol donor 
molecule, 3.1 pmol T2 template, and 3 units T4 DNA ligase at 
30 ºC for 18 h.   
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Table 3.3 Results of n-1 position investigation 
under optimized conditions. 
 
A4 
x = t 
C4 
 x = g 
G4 
x = c 
T4 
x = a 
ax-pxa 83.6 ± 0.2 (10.2 ± 0.2) 
81.9 ± 1.9 
(7.9 ± 1.0) 
89.4 ± 5.7 
(8.1 ± 5.5) 
84.0 ± 9.1 
(3.5 ± 1.4) 
cx-pxa 93.7 ± 1.5 (2.7 ± 1.0) 
76.5 ± 0.9 
(13.3 ± 2.3) 
97.9 ± 0.7 
(1.1 ± 1.1) 
93.6 ± 0.2 
(1.8 ± 0.4) 
gx-pxa     6.2 ± 0.3  ♦ (33.2 ± 1.4) 
67.6 ± 4.7 
(21.0 ± 3.6) 
78.9 ± 5.9 
(10.8 ± 3.9) 
86.5 ± 4.9 
(3.0 ± 0.2) 
tx-pxa 95.9 ± 0.5 (1.2 ± 0.2) 
83.1 ± 0.7 
(8.4 ± 0.8) 
93.6 ± 1.0 
(2.0 ± 0.7) 
87.7 ± 0.3 
(4.3 ± 1.1) 
ax-pxc 94.5 ± 1.6 (2.8 ± 1.4) 
51.9 ± 1.4 
(38.5 ± 1.5) 
98.3 ± 0.2 
(0.8 ± 0.1) 
97.8 ± 0.6 
(1.0 ± 0.3) 
cx-pxc 97.4 ± 1.1 (1.1 ± 0.4) 
   34.6 ± 1.7  ♦
(51.3 ± 4.5) 
98.4 ± 0.4 
(0.7 ± 0.2) 
98.0 ± 0.2 
(0.9 ± 0.2) 
gx-pxc    24.6 ± 9.1 ♦ (41.1 ± 3.6) 
73.9 ± 2.6 
(8.2 ± 0.3) 
97.3 ± 0.6 
(1.0 ± 0.1) 
81.7 ± 4.3 
(11.1 ± 0.6) 
tx-pxc 89.2 ± 7.3 (0.8 ± 0.2) 
   42.2 ± 8.2  ♦
(40.7 ± 6.7) 
97.8 ± 0.3 
(0.8 ± 0.1) 
86.1 ± 2.0 
(7.2 ± 4.9) 
ax-pxg 94.7 ± 1.7 (1.9 ± 0.8) 
96.3 ± 0.5 
(2.1 ± 1.0) 
87.0 ± 1.9 
(8.6 ± 0.1) 
97.0 ± 1.3 
(1.8 ± 0.7) 
cx-pxg 84.4 ± 1.6 (1.9 ± 0.8) 
95.4 ± 1.5 
(3.3 ± 2.1) 
94.8 ± 0.9 
(2.3 ± 0.6) 
97.0 ± 0.8 
(0.9 ± 0.2) 
gx-pxg 85.8 ± 5.0 (6.9 ± 2.6) 
96.4 ± 0.1 
(2.2 ± 0.8) 
97.2 ± 0.3 
(0.9 ± 0.1) 
96.6 ± 0.1 
(1.5 ± 0.1) 
tx-pxg 90.9 ± 5.8 (2.7 ± 1.7) 
95.7 ± 1.6 
(3.1 ± 2.0) 
97.5 ± 0.1 
(0.8 ± 0.1) 
95.4 ± 0.5 
(2.3 ± 0.1) 
ax-pxt 79.7 ± 5.8 (9.0 ± 3.3) 
93.4 ± 0.1 
(3.2 ± 0.1) 
91.5 ± 1.2 
(4.0 ± 0.8) 
97.7 ± 0.4 
(1.1 ± 0.4) 
cx-pxt 96.4 ± 1.6 (1.7 ± 0.8) 
94.9 ± 0.2 
(3.0 ± 0.7) 
94.6 ± 0.2 
(2.0 ± 0.1) 
92.6 ± 5.1 
(0.6 ± 0.1) 
gx-pxt 78.2 ± 1.4 (9.3 ± 2.5) 
92.5 ± 2.1 
(2.6 ± 0.5) 
95.0 ± 0.1 
(1.8 ± 0.1) 
97.1 ± 0.1 
(1.1 ± 0.1) 
tx-pxt 98.0 ± 1.4 (0.5 ± 0.1) 
92.6 ± 0.2 
(4.1 ± 0.1) 
94.8 ± 0.3 
(1.9 ± 0.1) 
96.8 ± 0.4 
(1.3 ± 1.3) 
Average 80.3 ± 26.5 (7.9 ± 11.9) 
79.3 ± 20.4 
(13.3 ± 16.0) 
92.8 ± 6.9 
(3.0 ± 3.2) 
92.9 ± 5.7 
(2.7 ± 2.8) 
The horizontal headings denote the template used, while the 
vertical labels refer to the newly ligated product. The x given in 
the vertical label is defined in the horizontal heading. The 
percent of product formed is shown in bold, with the amount of 
intermediate shown in parenthesis. Both values are shown with 
standard deviations. The averages for each template are also 
shown in the same format. The reactions were run with 30 mM 
Tris-HCl (pH 7.5), 10 mM DTT, 3 mM MgCl2, 10 µM ATP, 
20% DMSO, 2.5 pmol acceptor molecule, 70 fmol donor 
molecule, 3.1 pmol T2 template, and 3 units T4 DNA ligase at 
30 ºC for 18 h.   
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Table 3.4 Results of n and n-1 mismatch 
investigation under optimized conditions.  
 A4 C4 G4 T4 
aa-paa 2.7 ± 1.7 (56.2 ± 7.5) 
2.8 ± 0.8 
(47.7 ± 6.5) 
8.8 ± 1.8 
(15.8 ± 4.1) 
92.6 ± 1.4 
(3.7 ± 0.8) 
cc-paa 4.3 ± 0.1 (69.8 ± 9.2) 
4.8 ± 3.8 
(69.2 ± 1.6) 
86.6 ± 3.3 
(5.5 ± 1.6) 
91.7 ± 0.6 
(3.8 ± 0.3) 
gg-paa 2.4 ± 1.7 (46.5 ± 8.4) 
54.8 ± 4.9 
(20.4 ± 1.1) 
3.0 ± 0.8 
(15.4 ± 6.0) 
91.7 ± 0.4 
(3.6 ± 0.4) 
tt-paa 84.6 ± 2.6 (5.1 ± 0.3) 
4.2 ± 0.9 
(45.9 ± 10.2) 
7.3 ± 1.7 
(22.5 ± 7.9) 
88.5 ± 0.2 
(5.9 ± 0.7) 
aa-pcc 0.8 ± 0.3 (16.2 ± 6.5) 
0.5 ± 0.1 
(17.7 ± 8.7) 
75.8 ± 2.3 
(14.3 ± 3.7) 
79.4 ± 1.7 
(11.7 ± 1.1) 
cc-pcc 1.1 ± 0.1 (25.3 ± 5.0) 
2.2 ± 0.2 
(14.8 ± 3.2) 
88.7 ± 5.6 
(2.8 ± 0.3) 
65.7 ± 2.4 
(14.6 ± 2.1) 
gg-pcc 1.0 ± 0.1 (21.4 ± 8.4) 
31.2 ± 6.3 
(19.7 ± 4.8) 
91.1 ± 1.1 
(5.2 ± 0.7) 
22.6 ± 0.4 
(62.6 ± 0.4) 
tt-pcc 89.9 ± 0.1 (4.3 ± 1.0) 
3.1 ± 0.2 
(24.5 ± 3.4) 
96.1± 0.1 
(2.1 ± 0.3) 
87.6 ± 1.5 
(6.9 ± 0.8) 
aa-pgg 2.1 ± 0.1 (75.2 ± 15.8) 
89.1 ± 1.5 
(6.4 ± 1.6) 
77.1 ± 2.2 
(14.8 ± 0.6) 
96.1 ± 1.1 
(2.1 ± 0.7) 
cc-pgg 92.2 ± 0.4 (4.1± 0.1) 
91.4 ± 4.5 
(5.2 ± 3.3) 
95.5 ± 1.8 
(3.5 ± 0.3) 
76.2 ± 0.8 
(14.8 ± 0.4) 
gg-pgg 2.9 ± 0.3 (88.3 ± 1.1) 
93.2 ± 0.1 
(1.2 ± 0.3) 
47.1 ± 1.1 
(42.0 ± 2.1) 
87.4 ± 0.1 
(9.7 ± 0.3) 
tt-pgg 95.2 ± 1.3 (3.2 ± 1.0) 
92.4 ± 3.5 
(4.5 ± 2.6) 
72.4 ± 5.6 
(16.4 ± 1.0) 
39.4 ± 4.4 
(55.1 ± 5.0) 
aa-ptt 63.7 ± 5.2 (22.8 ± 6.4) 
8.3 ± 1.8 
(24.5 ± 6.5) 
7.9 ± 4.8 
(12.7 ± 9.1) 
88.9 ± 2.1 
(6.9 ± 2.3) 
cc-ptt 95.6 ± 0.3 (1.4 ± 0.3) 
20.8 ± 1.9 
(27.0 ± 4.4) 
89.7 ± 0.8 
(46.6 ± 0.1) 
27.5 ± 7.1 
(64.2 ± 10.0) 
gg-ptt 83.8 ± 3.1 (8.6 ± 8.3) 
55.2 ± 2.1 
(16.3 ± 1.2) 
2.4 ± 0.9 
(32.4 ± 1.1) 
7.6 ± 1.1 
(85.8 ± 0.8) 
tt-ptt 96.1± 0.4 (1.1 ± 0.3) 
52.4 ± 0.2 
(7.0 ± 2.2) 
5.2 ± 0.8 
(14.9 ± 0.4) 
29.4 ± 2.8 
(62.1 ± 3.7) 
Average 44.9 ± 44.8 (28.1 ± 29.5) 
37.8 ± 37.3 
(22.0 ± 18.4) 
53.4 ± 39.8 
(14.0 ± 11.1) 
67.0 ± 30.5 
(25.8 ± 28.8) 
The horizontal headings denote the template used, while the 
vertical labels refer to the newly ligated product. The percent of 
product formed is shown in bold, with the amount of intermediate 
shown in parenthesis. Both values are shown with standard 
deviations. The averages for each template are also shown in the 
same format. The reactions were run with 30 mM Tris-HCl (pH 
7.5), 10 mM DTT, 3 mM MgCl2, 10 µM ATP, 20% DMSO, 2.5 
pmol acceptor molecule, 70 fmol donor molecule, 3.1 pmol T2 
template, and 3 units T4 DNA ligase at 30 ºC for 18 h.   
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Table 3.5 Melting curve data for 
duplex systems using C4 template 
shown in Figure 3.5 
Acceptor/donor 
combination 
Tm (°C) 
gg-pgg 56.7 
tg-pgt 38.5 
cg-pgc 26.8 
tt-ptt 30 
The thermal denaturation experiments were run 
using a standard thermodynamic buffer composed 
of 20 mM sodium cacodylate, 1 M NaCl, and 0.5 
mM Na2EDTA at pH 7.0 using a 15 µM total 
strand concentration. Measurements were taken 
using a wavelength of 260 nM. Each Tm is the 
average of two independent denaturation 
experiments. 
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X Y G T G C T G Y XOH
A C G T G C T G G AOH
G C G T G C T G GGOH
C C G T G C T G G COH
T C G T G C T G G TOH
*pA C G T G C T G G A     pa
*pG C G T G C T G G G  pg
*pC C G T G C T G G C     pc
*pT C G T G C T G G T     pt
3’ G C A C G A C C T T G C A C G A C C 5’
3’ G C A C G A C C G G G C A C G A C C 5’
3’ G C A C G A C C A A G C A C G A C C 5’
3’ G C A C G A C C C C G C A C G A C C 5’
T2
G2
A2
C2
DONOR
TEMPLATES
Name
Studies Involving only the n Positions
*pX Y G T G C T G Y X
(ta  +  pat)  /  T4
Base Pairing
Adenylation
Ligation
3’ G C A C G A C T T T T C A C G A C C 5’
3’ G C A C G A C G G G G C A C G A C C 5’
3’ G C A C G A C A A A A C A C G A C C 5’
3’ G C A C G A C C C C C C A C G A C C 5’
yx
T4
G4
A4
C4
TEMPLATES
EXAMPLE
Name
Studies Involving the n-1 Positions
X = A, T, C, or G
Y = A, T, C, or G
3’ G C A C G A C T T  T T C A C G A C C 5’
A T G T G C T G T A*A T G T G C T G T A
n-1 positions
pxy
t
c
g
a
ACCEPTOR Name
(c  +  pg)  /  T2
Base Pairing
(starting material)
EXAMPLE
n positions
3’ G C A C G A C C T  T G C A C G A C C 5’
C C G T G C T G G C*G C G T G C T G G G
Ligation
(product)
Adenylation
(intermediate)
3’ G C A C G A C C T  T G C A C G A C C 5’
C C G T G C T G G COH C G T G C T G G G
*pG
3’ G C A C G A C C T  T G C A C G A C C 5’
C C G T G C T G G COH C G T G C T G G G
*pG
Ap
DONOR
ACCEPTOR
Figure 3.1. Diagram of investigation system for universal template study. On the left side, the n 
position system is shown, while the right side illustrates the n-1 position system. The acceptor 
and donor oligonucleotides are decamers, shown in lowercase lettering. Each one is named for 
the nucleotide with which it begins and ends. The donor decamers are phosphorylated via 
radiolabeled and shown in italics. The templates are in uppercase and denote the central 
universal template regions. The steps of the ligation reaction (adenylation and intermediate 
formation, and ligation) are shown. Once the decamers bind to the template, T4 DNA ligase 
catalyzes the formation of the covalent bond between the 3’ OH and the 5’ phosphate of the 
acceptor and donor, respectively.  
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Figure 3.2. Representative gel of ligation reactions run under standard conditions 
with the T2 template. The standard reaction conditions are 30 mM Tris-HCl (pH 
7.5), 10 mM DTT, 10 mM MgCl2, 1 mM ATP, 2.5 pmol acceptor molecule, 70 
fmol donor molecule, 3.1 pmol T2 template, and 3 units T4 DNA ligase at 30 ºC 
for 18 hours. The designations for P (product), I (intermediate), and S (starting 
material) are shown on the right side of the gel. The acceptor/donor combinations 
are shown above each lane. The first lane contains a 25-base size control, while 
the next four lanes are the donor oligonucleotides (unreacted); the following two 
lanes are the synthetic (a + pa) and (c + pa) size controls. The sixteen possible 
reactions are shown in the next four panels. The next three lanes are control 
reactions with (a + pa) without template, with template and treated with calf 
alkaline intestinal phosphatase (CIAP) after the reaction is completed, and 
without ligase.  
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Figure 3.3. Optimization of ligation conditions. Squares represent 
product and circles denote intermediate. The optimum MgCl2 
concentration of 3 mM was determined using (c + pc)/T2 as a test 
reaction. It was then used in the subsequent ATP-dependent assay 
shown in panel B. The inclusion of DMSO was tested in panel C 
using 3 mM MgCl2 and 10 µM ATP with the test reaction (c + 
pc)/C2. Time-dependence tests were run using (c + pc)/T2 in 3 mM 
MgCl2, 10 µM ATP, and 20% DMSO. Each data point was the 
average of two independent assays.  
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Figure 3.4. Representative gel of ligation reactions under optimized 
conditions with the T2 template. The standard reaction conditions are 30 mM 
Tris-HCl (pH 7.5), 10 mM DTT, 3 mM MgCl2, 10 µM ATP, 20% DMSO, 
2.5 pmol acceptor molecule, 70 fmol donor molecule, 3.1 pmol T2 template, 
and 3 units T4 DNA ligase at 30 ºC for 18 hours. The designations for P 
(product), I (intermediate), and S (starting material) are shown on the right 
side of the gel. The acceptor/donor combinations are shown above each lane. 
The first lane contains a 25-base size control, while the next four lanes are 
the donor oligonucleotides (unreacted); the following two lanes are the 
synthetic (a + pa) and (c + pa) size controls. The sixteen possible reactions are 
shown in the next four panels.  
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Figure 3.5. Time-dependence of ligation reactions. Each reaction was run 
under the optimized conditions, which were 30 mM Tris-HCl (pH 7.5), 10 
mM DTT, 3 mM MgCl2, 10 µM ATP, 20% DMSO, 2.5 pmol acceptor 
molecule, 70 fmol donor molecule, 3.1 pmol T2 template, and 3 units T4 
DNA ligase, at 22 °C. The ligation systems used were (gg-pgg)/C4, (cg-
pgc)/C4, (tg-pgt)/C4, and (tt-ptt)/C4. The symbol used for each system, 
along with its resultant kobs, is shown at the bottom right of the graph. Each 
data point was the average of two independently run assays.  
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Chapter 4 - Removal of Urea via 2-Butanol Extraction 
 
4.1 Materials and Methods for urea extraction via 2-butanol extraction 
4.1.1 Extraction and quantification procedure 
To generate an 8 M urea solution, approximately 150 mg of urea (Sigma-Aldrich) was 
dissolved in 2.5 mL water (at pH 7). This approximates the typical amount of urea in an 8 M 
urea denaturing gel slice and the typical volume of water used to diffuse the nucleic acid out of 
the gel slice. Therefore, in these experiments the initial aqueous phase contained 1 M urea. To 
each successive extraction an equal volume of 2-butanol (Fisher Scientific) was added, starting 
with 2.5 mL. Each extraction consisted of vortex-mixing the 2-butanol/water mixture for at least 
30 seconds and then separating the phases by centrifuging for 5 minutes at 3,000 rpm. Since 
water partitions into the 2-butanol phase during each extraction (50), successive equal volume 
extractions (pH 7) resulted in successively smaller 2-butanol and aqueous solution volumes, and 
were discontinued once less than 100 µL of aqueous solution remained (culminating in a total of 
five extractions). To determine the effect of 2-butanol volume on extraction properties, a large 
volume extraction series (at pH 7) was conducted. In these experiments, 1.5 times (1.5X) more 
2-butanol than aqueous solution was added in each extraction. Because more 2-butanol is added, 
more water can partition into the 2-butanol phase per extraction. Therefore, the water volume is 
reduced to less than 100 µL in 3 (rather than 5) extractions. The 2-butanol phase of each 
extraction was then dried completely in a Juoan RC10.10 centrifugal evaporator. The amount of 
urea that partitioned into the 2-butanol phase for each extraction was quantified by weighing the 
urea-containing tube and subtracting the weight of the tube. The sum of the urea extracted and 
that remaining in the aqueous phase weighed within 10% of the starting amount of urea for each 
extraction series, indicating the accuracy of the experimental method. Each extraction series 
reported is the average of three independent experiments. 
 
4.1.2 Extractions with nucleic acid 
 Extractions on samples with nucleic acid had approximately 1 pmol of 5’ end 
radiolabeled Oligo1, d(CTGTGCTGAC), added into the initial 2.5 mL aqueous solution. These 
extractions were conducted using samples with or without urea. Oligo1 was purchased from and 
HPLC purified by Integrated DNA Technologies (Coralville, IA) and was radiolabeled as 
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previously described (31). The equal volume extraction strategy outlined above was followed. 
The amount of radiolabeled Oligo1 remaining in each 2-butanol extraction and in the aqueous 
phase was quantified by blotting 10 µL (out of 200 µL total) of each dried and resuspended 
extraction on a Baker Si250F thin layer chromatography (TLC) plate and analyzing the TLC 
plate radiation with a Molecular Dynamics STORM 860 Phosphorimager.  
 
4.2 System Design 
 The purpose of this study was the investigation of 2-butanol extraction as an effective 
method to remove urea from aqueous nucleic acid samples. In the extractions, an 8M urea 
solution was generated and extracted with equal and large (1.5X) volumes of 2-butanol until a 
minimal amount of solution (100 µL) remained. The amount of urea removed with each 
extraction was measured and the results were evaluated with respect to the volume used in the 
extraction and the concentration of urea in both the aqueous and butanol phases. The extractions 
were also duplicated with an addition of radiolabeled oligonucleotide to observe whether or not 
the urea removal left the nucleic acid behind in the aqueous phase. The levels of radioactivity 
were quantified to establish if urea had an effect on the partitioning of the nucleic acid into either 
the aqueous or the butanol phase.  
 
4.3 Results 
Figure 4.1 depicts the percent of urea that remained in the aqueous solution (at pH 7.0) 
with respect to the number of 2-butanol extractions. All of the data points shown were the results 
of three separately run assays with standard deviation values shown as error bars. When an equal 
volume of butanol was used, five extractions were performed (squares). In cases of large volume 
extractions, three extractions were done (circles). Regardless of the volume of the extraction 
used, approximately 3% of the urea originally in solution remained. This reduction of 97% (150 
mg to 4.5 mg) was further evidenced by the considerable amount of urea eliminated in each 
extraction. These results indicated a reproducible and quantitative removal of urea via 2-butanol 
extraction.  
 Figure 4.2 shows the molar concentration of urea remaining in each phase after each 
extraction. Again, equal volume extractions are denoted with squares and large volume with 
circles and the values shown are from three independent assays. The error bars correlate with the 
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standard deviation values. The solid symbols correspond to the urea concentration remaining in 
the aqueous phase, while the open symbols represent the urea concentration in the 2-butanol 
phase. Urea concentrations in both the butanol phase and aqueous phases (0.29 M ± 0.04 and 
0.91 M ± 0.12, respectively) after each of the equal volume extractions were relatively constant. 
Results in the case of the large volume extractions were in essence the same (0.26 M ± 0.04 and 
0.89 M ± 0.12, respectively).  
In order to answer the question of how the urea was being carried into the 2-butanol 
phase, the data was charted as a function of the water that reallocated into the 2-butanol phase 
(Figure 4.3). This differed from Figure 4.2, which took into consideration both phases; this 
analysis took into account only the water that is taken into the butanol phase. The designations 
for equal and large volume extractions mirrored those previously mentioned and the data shown 
is from three independent experiments, with the standard deviations again shown as error bars. It 
was apparent from the results that after the first extraction, the values remained relatively 
constant. The concentration of urea and water in the 2-butanol phase was 0.82 M ± 0.07 for the 
equal volume extractions and 0.84 M ± 0.07 for the large volume extractions. These results fell 
within the standard deviations of the urea concentrations in the respective aqueous phases shown 
in Figure 4.2.  
 Nucleic acids partitioned poorly into the butanol phase; henceforth, 2-butanol extraction 
provides an attractive method for the concentration of nucleic acids. The next step in the 
investigation examined whether or not the presence of urea in aqueous nucleic acid solutions 
affects the partitioning of nucleic acids between the two phases. Equal volume 2-butanol 
extractions were performed as above with samples that contained urea and samples that did not; 
these samples additionally contained a trace amount of radiolabeled Oligo1. The presence or 
absence of urea did not affect the volume of water redistributed per extraction (data not shown). 
The amount of radiolabeled nucleic acid that was carried into the 2-butanol phase, as well as 
what remained in the aqueous phase, was quantified and is presented in terms of the nucleic acid 
lost per 2-butanol extraction (Table 4.1). The equal volume extractions were performed in 
duplicate. In the case of the urea-containing solution, the extractions resulted in an average loss 
of 6.2% per extraction. For the solution without urea, the extractions produced an average loss of 
7.7% per extraction.  
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4.4 Discussion 
Extraction with 2-butanol yielded a consistent and significant elimination of urea from 
aqueous solutions, as shown in Figure 4.1. The results obtained with the equal and large volume 
extractions provide evidence that the concentration of urea in each phase was not dependent on 
the volume of 2-butanol added (Figure 4.2). Moreover, the urea concentration in each phase did 
not depend on the volume of aqueous solution remaining, when comparing the different volumes 
in each of the extractions. It seemed that a concentration equilibrium was established between 
the two phases. The aqueous phase possessed roughly a 3-fold higher concentration of urea than 
the butanol phase. This suggested that the urea is not very soluble in the 2-butanol, if at all.  
As for how the urea was removed from the solution, it seemed that most, if not all, of the 
urea carried into the 2-butanol phase by the redistributed water. Apparently, the urea did not 
dissolve in the 2-butanol directly to any great extent. The equilibrium that prevailed between the 
phases, as well as the amount of urea extracted, were functions of the amount of water that 
reallocated into the 2-butanol phase. Thus, the large volume extractions removed the same 
amount of urea in fewer extractions, as more water partitioned into the 2-butanol phase.  
In every extraction series performed, merely 10% to 20% of the total aqueous volume 
redistributed from the aqueous phase into the 2-butanol phase in the first extraction (data not 
shown). On the contrary, each subsequent extraction removed approximately 60% of the 
remaining aqueous volume. This reflected the differences in urea concentrations shown in Figure 
4.3. This implied a difference between the first extraction and those following it. Yet, the 
concentration of urea in the 2-butanol phase was the same for every extraction, including the first 
extraction (Figure 4.3). One probable explanation for such results was that the 2-butanol 
saturates the aqueous phase. This led to additional volume in the aqueous phase, which 
established an equilibrium in the first extraction. This intimated that more water partitioned into 
the 2-butanol phase in the first extraction than what could accurately be determined. Perhaps, 
some of it was being replaced in the aqueous phase by 2-butanol. This might have explained the 
higher urea concentration in the first extractions that is shown in Figure 4.3.  
 The extraction data obtained using a solution containing nucleic acids illustrated that the 
presence of urea in the aqueous solution did not substantially affect the partitioning of the 
nucleic acid between the two phases. As evidenced from the data, the average amount of nucleic 
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acid lost per extraction differed only slightly depending upon whether or not urea was present 
(6.2% versus 7.7%).  
 
4.5 Implications 
These results demonstrated that the extraction of aqueous nucleic acid solutions utilizing 
2-butanol removes urea. In addition, the presence of urea when concentrating such solutions by 
2-butanol extraction did not affect the partitioning of the nucleic acids or increase the amount 
that may be lost per extraction. This study offered a simple method for removing urea from 
nucleic acid samples, including those purified from denaturing polyacrylamide gels. Water could 
be added so that additional 2-butanol extractions could be done if further urea extraction is 
desired. On the other hand, butanol extraction removed enough urea such that other forms of 
purification (i.e. ethanol precipitation or column chromatography) could be more successful. In 
terms of the volume of 2-butanol to add for each extraction, both the equal and large volume 
extractions yielded a ≥ 95% elimination of urea in aqueous solutions. Large volume extractions, 
however, have the advantage of decreasing the total number of extractions required, which will 
probably reduce the amount of nucleic acid lost to the 2-butanol phase. Unfortunately, using an 
even larger volume of 2-butanol increases the likelihood that all of the water, nucleic acid, and 
urea will partition into the 2-butanol phase. 
To conclude, this study has proven that the extraction of urea from nucleic acids via 2-
butanol is an effective method in cases of high urea concentrations. In these situations, other 
methods routinely fail. In addition, it is shown here that the urea does not dissolve into the 2-
butanol phase directly, but is “taken into” the 2-butanol phase with the water that is redistributed 
into it. This simple, yet efficient new strategy for purification is useful in the enhancement 
nucleic acid purity for use in a myriad of molecular biology applications. 
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Table 4.1 Loss of nucleic acid per equal 
volume 2-butanol extraction with and 
without urea 
Extraction # With urea Without 
urea 
1 5.6% 5.7% 
2 12.5% 8.7% 
3 2.1% 0.3% 
4 2.8% 13.5% 
5 8.2% 10.3% 
Average 
loss per 
extraction 
6.2% 7.7% 
Each extraction set was performed with 1 pmol of 
radiolabeled Oligo1 in a 2.5 mL aqueous solution. In 
those extractions with urea, the concentration of urea 
was approximately 8 M. The amount of nucleic acid 
remaining was quantified by blotting  10 µL of a 200 
mL solution onto a TLC plate and comparing the 
radioactive intensity. All of the percentages were 
obtained by averaging two separate assays.  
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Figure 4.1. The percent urea remaining in the original aqueous solution (at pH 
7.0) versus the number of 2-butanol extractions. Equal volume extractions are 
shown with squares, while the large volume extractions are denoted with 
circles. Each data point was obtained by triplicate extractions with the standard 
deviations shown as error bars. 
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Figure 4.2. The concentration of urea (in M) remaining in each phase after 
each extraction. Equal volume extractions are shown with squares, while the 
large volume extractions are denoted with circles. The concentration of urea 
shown in each data point takes into account the remaining volume of each 
phase. Each data point was obtained by triplicate extractions with the 
standard deviations shown as error bars. 
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Figure 4.3. The concentration of urea (in M) per volume of water (in mL) that 
redistributes into the 2-butanol phase for each extraction. Equal volume 
extractions are shown with squares, while the large volume extractions are 
denoted with circles. This graph takes into account the volume of water taken 
into the butanol phase for each extraction. Each data point was obtained by 
triplicate extractions with the standard deviations shown as error bars. 
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Chapter 5 - RNA Replacement via Ribozyme-Catalyzed 5’ Transcript Replacement 
 
5.1 Materials and Methods for the 5’ Replacement Splicing Study 
5.1.1 Oligonucleotide Synthesis and Preparation  
DNA oligonucleotides were purchased from Integrated DNA Technologies (Coralville, 
IA). RNA oligonucleotides were purchased from Dharmacon, Inc. (Boulder, CO) and 
subsequently deprotected with the manufacturer’s protocol. RNA substrates were radiolabeled at 
the 3’ termini using modifications to a two-step procedure previously described (98). First, 
cytidine monophosphate (Cp) was radiolabeled at the 5’ termini by incubating 10 µM Cp, 0.85 
µM [γ-32P] rATP (Amersham Pharmacia, Piscataway, NJ), 70 mM Tris-HCl (pH 7.5), 50 mM 
KCl, 10 mM MgCl2, 5 mM dithiothreitol (DTT), 0.1 mM EDTA, 0.1 mM rATP, 10% glycerol 
and 10 units T4 Polynucleotide kinase (New England Biolabs, Beverly, MA) in a reaction 
volume of 10 µL for 1.5 h at 37 °C. The kinase was heat-inactivated at 65°C for 15 minutes. 
Next, 2 µM of the RNA substrate was ligated to the prepared *pCp in a reaction with 0.28 µM 
*pCp, 50 mM Tris-HCl (pH 7.4), 50 mM KCl, 10 mM MgCl2, 10 mM DTT, 1 mM rATP, 
0.1mM EDTA, 10% dimethyl sulfoxide (DMSO), and 20 units of T4 RNA ligase (New England 
Biolabs) at 4 °C for ≥ 16 h. The products were gel purified as described (31). 
 
5.1.2 Plasmid Construction and Synthesis  
The P. carinii ribozyme plasmid precursor, P-8/4x, was generated as previously 
described (31). The plasmid containing the initial 5’ replacement splicing ribozyme was derived 
from the P-8/4x plasmid and designated PKA. A number of alterations were required to generate 
this plasmid (Figure 5.1). First, an Age I site was engineered into the P2 helix region of the 
plasmid containing the ribozyme (Step 1 of Figure 5.1). This new and unique restriction site was 
used in conjunction with an existing Sfi I site upstream of the T7 promoter to create an insertion 
site for a double-stranded oligonucleotide fragment containing a T7 promoter, the new 5’ exon, 6 
bases of the L1 loop native to the P. carinii intron, and the RE1 and RE3 recognition elements 
(Step 2 of Figure 5.1). This insert replaces the T7 promter and the IGS (RE1 and RE3) of the P-
8/4x of the ribozyme (31). Last, the RE2 region was modified specifically for the targeted 
portion of the k-ras gene (Step 3 of Figure 5.1).  
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A full description of the methods used follows. A unique Age I site was created in the 
starting plasmid (P-8/4x) via site-directed mutagenesis using primers 5’ 
CATGAAACCGGTGTGAAAACGTTAGGTAGTG 3’ and 5’ 
CACTACCTAACGTTTTCACACCGGTTTCATG 3’. The amplification reaction contained 15 
pmol of each primer, 25 ng of parental plasmid, 2.5 units of Pfu DNA Polymerase from 
Stratagene (La Jolla, CA) and 0.5 µM dNTPs in a reaction buffer of 10 mM KCl, 10 mM 
(NH4)2S04, 20 mM Tris-HCl (pH 8.8), 2 mM MgSO4, 0.1 % Triton X-100, and 0.1 mg/mL BSA; 
the total reaction volume was 50 µL. After initial denaturation for 30 seconds at 95 ºC, the 
mixture underwent 15 cycles of 95 ºC for 30 seconds, 55 ºC for 2 minutes, and 68 ºC for 6 
minutes. The parental plasmid was digested with 20 units of DpnI from New England Biolabs in 
4.1 µL of the manufacturer’s buffer for 1 hour at 37 ºC. Transformation of E. coli DH5α 
competent cells from Invitrogen (Rockville, MD) was performed with 3 µL of this reaction 
according to the manufacturer’s specifications. Purification of the vector utilized the QIAPrep 
Miniprep Kit (QIAGEN, Valencia, CA). The resulting plasmid was digested with 25 units of 
Age I (New England Biolabs) in 7.5 µL of the manufacturer’s buffer at 37 ºC to fully cleave 25 
µg of the plasmid; the newly linearized plasmid was purified with the QIAquick PCR 
Purification Kit (QIAGEN). The linear plasmid was digested a second time with 40 units of SfiI 
(New England Biolabs) in 20 µL of the manufacturer’s buffer and 2 µg of BSA at 50 ºC. The 
plasmid was run on a 1.5% agarose gel. The band containing the plasmid was excised and 
purified using the QIAquick Gel Extraction Kit (QIAGEN). To prevent recircularization without 
the insert, the 15 µg of plasmid was dephosphorylated by incubation with 4 units of calf 
intestinal alkaline phosphatase (CIAP) in 6 µL of the manufacturer’s buffer at 37 ºC for 1 hour. 
Purification of the plasmid was done using the QIAquick PCR Purification Kit (QIAGEN).  
Next, 300 pmols of each oligonucleotide of the insert were phosphorylated by incubation 
with 1 mM rATP and 10 units of T4 Polynucleotide kinase (New England Biolabs) in 5 µL of 
the supplied buffer at 37 ºC for 1 hour; the total reaction volume was 50 µL. The reactions were 
purified using the QIAquick Nucleotide Removal Kit (QIAGEN). Approximately 9 pmols of 
each strand of the deoxyoligonucleotide fragment were combined and preannealed at 80 ºC for 5 
minutes and added to 10 µg of the double-digested plasmid with 21 units of T4 DNA ligase 
(Promega, Madison, WI) with 2 µL of the supplied buffer. Ligation proceeded overnight at 22 
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ºC. Transformation of E. coli DH5α cells with 5 µL of the ligation reaction using the 
manufacturer’s specifications resulted in a vector purified with the QIAPrep Miniprep Kit 
(QIAGEN). Two more successive rounds of site-directed mutagenesis were performed with the 
following sets of primers to alter the RE2 region: 1) 5’ 
GCTTAAGGTATAGTCTGTCAAAAACCTCTTTCG3’ and 5’ 
CGAAAGAGGTTTTTGACAGACTATACCTTAAGC3’; 2) 
5’GGTATAGTCTGTCAAGGCCCTCTTTCGAAAG3’ and 5’ 
CTTTCGAAAGAGGGCCTTGACAGACTATACC 3’. This new plasmid was designated PKA-
6/8/6 to reflect the base plasmid (PKA) and the length of the L1 loop/RE2 region/RE3 region. 
The plasmid was sequenced by Davis Sequencing (Davis, CA) to confirm the changes. Any 
further changes to test the length dependence of RE2, RE3, or the L1 loop were performed via 
the site-directed mutagenesis technique described previously with the primers specific for the 
changes desired.  
 
5.1.3 Transcription 
  The plasmid was linearized using Xba I (Invitrogen) and purified using the QIAquick 
PCR Purification Kit (QIAGEN) prior to runoff transcription. The transcription reaction was run 
as previously described (31) and purified with the QIAGEN-tip 100 anion-exchange columns 
(QIAGEN) using the following protocol: the column was first equilibrated with 4.0 mL Buffer I 
(750 mM NaCl, 50 mM MOPS (pH 7.0), 15% ethanol, and 0.15% Triton X-100). The 
transcription reactions were subsequently loaded on the column and the column washed with 7.0 
mL of Buffer I. Finally the transcription products were eluted with 4.0 mL of Buffer II (1.0 M 
NaCl, 50 mM MOPS (pH 7.0), and 15% ethanol). The eluted products were isopropanol 
precipitated, ethanol precipitated, and reconstituted in sterile water and quantified with a 
Beckman UV-VIS DU-650 spectrophotometer. 
 
5.1.4 5’ Replacement Splicing Reactions  
Reactions were run in HxMg buffer composed of 50 mM HEPES (25 mM Na+), 135 mM 
KCl, and x mM MgCl2 at pH 7.5, where x is from 0 to 200.  Prior to each reaction, the ribozyme 
was added to a solution of sterile water and the appropriate buffer at a 100 nM concentration (0-
400 nM ribozyme in concentration-dependent assays) and preannealed at 60 ºC for 5 minutes. 
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The ribozyme solution was allowed to cool to the reaction temperature listed in the figures. In 
the studies analyzing the effect of guanosine monophosphate (GMP) on the 5’ replacement 
splicing reactions, GMP concentration ranged from 0-300 µM and the specific amount of GMP 
being tested was added to the ribozyme solution prior to preannealing. Temperatures tested 
during optimization ranged from 22-60 ºC. The reaction was initiated by the addition of a 1 µL 
aliquot of a solution containing radiolabeled substrate in the appropriate buffer at a 8 nM 
concentration to give a final volume of 6 µL. The reaction time was tested from 1-24 h. The 
reactions were terminated by adding an equal volume of stop buffer (10 M urea, 3 mM EDTA, 
and 0.1X TBE), followed by denaturation at 90 ºC for 1 minute.  Products and reactants were 
separated on a 14% polyacrylamide/8M urea gel.  The gel was transferred to chromatography 
paper (Whatman 3MM CHR) and dried under vacuum.  The bands were visualized and 
quantified on a Molecular Dynamics Storm 860 Phosphorimager. The results shown are the 
average of 2 independent assays. In all cases, the standard deviations were in the range of ±10% 
of the average of the 2 assays. Observed rate constants were quantified by fitting the data from 
the time dependence studies to a simple exponential function.  
 
5.1.5 Sequencing Protocol for 5’ replacement splicing reaction product 
 The 5’ replacement splicing reaction was run using the 12:1 ribozyme to substrate ratio 
described above (optimized with respect to the ribozyme concentration), but with non-
radiolabeled substrate and 5 µL of the reaction was added to 5 pmol of a template 
oligonucleotide with the sequence 5’ 
GCACAGGGACCTGTATGTCAAGGCACTCGTCCCTTCCG 3’, 3.3 pmol of linker 2A (5’ 
TGCTCAGGCTCAAGGCTCGTCTAATCACAGTCGGAAGGGAC 3’), 3.3 pmol of linker 1B 
(5’ GTCCCTGTGCTGACATGAATGACCGACTTGAGTGACCTGGCA 3’) and 6 units of T4 
DNA ligase (Promega) under the manufacturer’s conditions for 18 h at 4 ºC. The ligation 
reaction was purified using QIAquick Nucleotide Removal Kit (QIAGEN) to isolate the 5’ 
replacement splicing product with both linker oligonucleotides attached. Next, 5 µL of the 
purified ligation product was used in an RT-PCR reaction utilizing the Access RT-PCR kit from 
Promega under the manufacturer’s conditions. The RT-PCR primers used were P1 (5’ 
TGCCAGGTCACTCAAGTCGGTCATTCATGTCA 3’) and P2 (5’ 
TGCTCAGGCTCAAGGCTCGTCTAATCACAGT 3’). The amplified product was purified via 
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the QIAquick Gel Extraction kit (QIAGEN) and ligated into the pDrive Cloning Vector from 
QIAGEN. The ligation was run under the manufacturer’s conditions for 1.5 h at 4 ºC. Last, E. 
coli DH5α cells were transformed with 5 µL of this ligation reaction using the manufacturer’s 
specifications; the resultant vector was purified with the QIAPrep Miniprep Kit (QIAGEN). The 
plasmid was sequenced by Davis Sequencing to provide confirmation of the 5’ replacement 
splicing product.  
 
5.2 Principle of Ribozyme-Catalyzed 5’ Transcript Replacement 
5.2.1 Proposed Mechanism 
The purpose of this study was the engineering of a ribozyme that could replace the 5’ end 
of a mutant RNA with a corrected version in a small model system. Note that this differs from 3’ 
replacement splicing, which uses 5’ recognition elements as primary determinants of substrate 
targeting. This ribozyme utilizes three recognition elements in the reaction: RE1, RE2 and RE3. 
RE1 base pairs with the new 5’ exon (covalently attached to the ribozyme) to form the P1 helix. 
RE2 base pairs with the 5’ end of the substrate to form the P9.0 helix (Figure 2.15), while RE3 
forms the P10 helix with the 3’ end of the substrate. Connecting the new 5’ exon and the 
remainder of the ribozyme is a hairpin loop (labeled L1) that is native to the P. carinii intron 
(31).  
 
5.2.2 Design of the 5’ Replacement Splicing System  
The system design is shown in Figure 5.2. In both panels A and B, the 5’ replacement 
splicing ribozyme is in blue uppercase lettering, the 16-mer substrate is in green lowercase 
lettering. In panel A, the exon regions to be ligated are in bold. The ribozyme recognition 
element RE1 base pairs with the 5’ exon-ribozyme conjugate to form the P1 helix (an 
intramolecular interaction). The ribozyme recognition elements RE2 and RE3 base pair with the 
substrate to form the P9.0 and P10 helices, respectively. The P10 helix is boxed. The first design 
principle is used for this system is shown in Step 1 of Figure 5.2; it consists of the conserved 
base-pair formed by a guanosine (gray) in the ribozyme and a uridine (blue) in the substrate, or 
the 5’ replacement exon in this case. This interaction defines the first catalytic site and is denoted 
with an arrow. The second principle is the required ωG, in the substrate (red) that defines the 
second catalytic site; this site is also denoted with an arrow. These first two design principles 
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involve the previously mentioned conserved and required elements of group I intron-derived 
ribozymes.  
The sequence of the gene k-ras was used as a target because of the location and nature of 
the previously mentioned mutation hotspot, codon 12 (which is heavily linked to lung cancer). 
The small model substrate is a short synthetic portion of the k-ras gene that is 15 nucleotides in 
length and contains codons 18-22 (Figure 5.2). Codon 20 best suited the design principles 
necessary for a splice site and it is located downstream of codon 12. Therefore, the 5’ 
replacement splicing reaction will replace everything upstream of (or 5’ to) codon 20 (including 
codon 12, which is not included in this small molecule model system). The new 5’ exon is 
attached to the ribozyme via a normal phosphodiester bond (to produce a 5’ exon-ribozyme 
conjugate) and contains the last base in codon 16 through the last base in codon 20 of the k-ras 
gene. The last base of codon 20 in the new 5’ exon is a uracil, which replaces the guanosine at 
this position in the original transcript. This will not change the amino acid sequence of the 
resultant protein product (Figure 5.2B). This concerns the third principle of design, which is the 
targeting of guanosines within a sequence that could yield silent mutations when the guanosine is 
replaced with uridine in the final product. Panel B of Figure 5.2 displays this with the amino acid 
sequences of both substrate and product.  
The 5’ replacement splicing reaction in this small model system was expected to result in 
a product 19 bases in length. The 3’ radiolabeling procedure performed on the substrate allowed 
visualization of the reaction; it also resulted in an additional cytosine on the 3’ end of the 
substrate (16 bases) and product (20 bases). 
 
5.3 Results 
5.3.1 Initial System and Optimization 
The initial test ribozyme contained the new 5’ exon, 6 bases of the L1 loop found in the 
P. carinii intron (31), a 6-base RE1, an 8-base RE2, and a 6-base RE3 (shown in Figure 5.2). The 
lengths of the recognition elements were derived from previous work on the TES reaction that 
indicated longer P9.0 regions to be beneficial, as well as P10 regions up to 6 bases in length (99).  
The reaction resulted in the first-reported ribozyme-catalyzed replacement of the 5’ 
portion of an RNA substrate in an optimized yield of 33.1% ± 2% (the average of four 
independently run assays) (representative polyacrylamide gel in Figure 5.3A). Reactions were 
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run using 100 nM rPKA-6/8/6 ribozyme, 8 nM radiolabeled substrate, and 50 mM MgCl2 at 44 
°C for 20 h. The first lane contains the synthetic reaction product; the second lane contains the 5’ 
replacement splicing reaction with the 16-mer substrate yielding the 20-mer product. The third 
lane shows an alkaline digest of the synthetic product, and the fourth lane shows the 16-mer 
starting material under reaction conditions with no ribozyme. Shown to the right of the gel are 
the sequences and the sizes of the substrate and product. Note the radiolabeled cytosine on the 3’ 
end of both the substrate and the product. In these studies, the MgCl2 concentration, reaction 
temperature, and reaction time were optimized (Figure 5.3B), as well as the effect of the 
concentration of the 5’ exon-ribozyme conjugate. The MgCl2 dependence was tested from 0 to 
200 mM, with 50 mM corresponding to the highest product yield. The reaction was analyzed at 
temperatures ranging from 0 to 60 °C; 44 °C yielded the highest amount of product. Time 
dependence reactions ranged from 0 to 24 h; maximum product yield was obtained at 20 h. All 
data points shown result from two separate assays and have standard deviation values under 
10%. Under optimized conditions, a kobs value of 1.58 x 10-3 min-1 was obtained. The 
concentration dependence of the 5’ exon-ribozyme conjugate was tested from 0 to 400 nM; 
maximum product formation could be obtained with a concentration of 100nM. Each factor was 
investigated at 50 mM MgCl2, 44 ºC, and 20 h using a 12-fold excess (100 nM) of ribozyme over 
radiolabeled substrate (8 nM), changing only the variable being tested, as shown in Figure 5.3B.  
 
5.3.2 Length Dependence of P9.0  
The length of the P9.0 region was investigated as it relates to the product yield of the 
reaction. The region was tested in increments of 2, resulting in P9.0 helices of 2, 4, 6 and 8 base 
pairs (Figure 5.4A). The reactions were run with 100 nM ribozyme, 8 nM substrate, and 50 mM 
MgCl2 at 44°C for 20 h. All data points have been done in duplicate; the standard deviation for 
all points is less than 10%. Both RE3 and the L1 loop were each at 6-base lengths. As the length 
of the P9.0 region increased, so did the percentage of product formed. From these tests, it was 
determined that a longer length for the P9.0 helix was beneficial. The length of the small model 
substrate did not allow for the testing of a P9.0 longer than 8 bases; however, longer lengths 
could prove even more beneficial.  
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5.3.3 Length dependence of P10 and the native loop  
The length of the P10 region was also tested in terms of its effect on product yield. Due 
to the position of P10 and the adjacent L1 loop, however, the analysis had to consider the effects 
of the length of both regions simultaneously. Decreasing the number of bases in the RE3 region 
would not necessarily result in a shortened P10 helix, as bases in the L1 loop could participate in 
P10 formation (see Figure 5.2A). For example, a 4-base RE3 (5’GUAU3’) would still result in a 6 
base RE3 and a 6-base pair P10 helix, with a U•G base-pair at the 5’ end of the P10 helix. The 
additional 2 bases would be from the 3’ terminal uridines in the L1 loop, resulting in a 4-base 
loop (5’CACC3’). Thus, the effect of both factors was investigated simultaneously, using a 6-base 
pair and a 1-base pair P10 (Figure 5.4, B1 and B2). Each of the reactions were run under the 
same conditions the P9.0 length dependence used; these data points are also the average of two 
independently run assays with standard deviations under 10%. In each case, the P9.0 length was 
8 base pairs. With each P10 region, analysis was done on loop lengths from 2-14, advancing in 
increments of 2. The longest length is shown to the right of each graph. Uridines were used when 
lengthening the loop because they are the least likely base to form intermolecular and 
intramolecular structures. As can be seen from Figure 5.4B1 and 2, a longer P10 alone was 
beneficial in terms of product yield. When the P10 region consisted of only 1 base pair, reaction 
percentages did not reach over 10%, regardless of loop length. At various loop lengths with a 1-
base pair P10, it appeared that any effect loop length could have on product formation was likely 
undetectable due to the detrimental effect of decreasing the length of P10. Once P10 was 
increased to 6 base pairs, the product percentages also increased as loop length increases. Note, 
however, that this was not a precise trend, as a 10-base loop paired with a 6-base RE3 provided 
the optimal level of product formation for the 5’ replacement splicing reaction.  
 
5.3.4 Optimized Construct Investigation 
From this data, an ‘optimized’ ribozyme construct (with a 10-base L1 loop, an 8-base 
RE2, and a 6-base RE3) was developed. It was scrutinized to find out if it reacted differently to 
changes in MgCl2, temperature, time and 5’ exon-ribozyme conjugate concentration (Figure 5.5) 
in comparison to the initial ribozyme construct. A representative gel of the reaction is shown in 
Figure 5.5A. The reactions used 100 nM ribozyme, 8 nM radiolabeled substrate, and 50 mM 
MgCl2 at 44 °C for 20 h. The first lane contains an alkaline digest of the synthetic product; the 
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second lane contains the 5’ replacement splicing reaction with the 16-mer substrate yielding the 
20-mer product. The third lane shows the synthetic reaction product; and the fourth lane shows 
the 16-mer starting material only under reaction conditions without ribozyme. To the right of the 
gel are the sequences and sizes of the substrate and product. Note again the radiolabeled cytosine 
on the 3’ end of both the substrate and the product. The optimized reaction yielded 73.6% ± 0.1 
product (average of four independently run assays), which is twice as much as seen with the 
initial ribozyme construct. Magnesium chloride, temperature, and 5’ exon-ribozyme conjugate 
concentration dependence studies on this system yielded the same values for optimum product 
formation (50 mM, 44 °C, 20 h).  The reactions were run as described above except for the 
changing variable; all data points have been done in duplicate with standard deviations below 
10%. 
The results from the time dependence study of the 5’ exon-ribozyme conjugate did, 
however, yield different results from the initial system. From this time study, a kobs value of 9.17 
x 10-3 min-1 was obtained. This rate constant was almost 6-fold greater than that of the first 
construct. With the exception of the rate constant increasing, the remaining reaction parameters 
did not change. This implied that they were inherent traits of the catalytic core of this ribozyme 
construct as opposed to related to the recognition elements or loop region.  
 
5.3.5 Sequencing Confirmation 
 To sequence the 5’ replacement splicing product, a sequencing protocol used with small 
RNAs was modified (100-101). With this protocol (shown in Figure 5.6), linker oligonucleotides 
are ligated to the product to be sequenced. The DNA linker molecules and the DNA template are 
shown in black, while the 5’ replacement splicing product is shown as an open line. The template 
was complementary to the 5’ replacement splicing product, as well as the 3’ end of the 2A and 
the 5’ end of the 1B linker. The template did not, however, contain the complement to the new 
uridine that is present in the product. As a result, there was a 1-nucleotide bulge when all three 
molecules were bound. This ensured that if the new uridine was present in the sequenced 5’ 
replacement splicing product, it could only have been obtained from the correct reaction product, 
as opposed to non-specific interaction with the template molecule. The linkers and reaction 
product bound to the template and were ligated together. These linker oligonucleotides added 
length to the product that enabled RT-PCR amplification of it using RT-PCR primers (shown as 
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solid lines) that corresponded only to the portions of the linkers that did not interact with the 
DNA template. Because there was no complementary base for the new uridine found on the 5’ 
replacement splicing product, any amplified RT-PCR product containing the new uridine could 
only have come from the reaction product and not from non-specific interactions with the 
template. The amplified ligated product was purified and subsequently underwent ligation into a 
plasmid. Sequencing of the resultant plasmid revealed the expected 5’ replacement splicing 
product sequence, and confirmed that the reaction occurred as expected.  
 
5.3.6 Effect of GMP on the 5’ replacement splicing reaction  
After optimization of the new ribozyme construct, the next step was the investigation into 
the effect of GMP on the reaction. This reaction does bear similarities to ribozyme 3’ 
replacement, which requires a guanosine cofactor (Figure 2.13). In addition, the G-addition 
reaction could occur in the first reaction step instead of the hydrolysis reaction (in a cell, for 
example). Therefore, it was important to ascertain how the addition of such a cofactor would 
affect this reaction. These reactions were run just as the optimization reactions; the only 
difference is the addition of GMP to the reaction. As seen in Figure 5.7, the addition of various 
concentrations of GMP clearly lowers the product levels in the analyzed reaction. Even at a 
concentration of 1 µM, the amount of 5’ replacement splicing product decreases. Each of the 
data points were from duplicate assays with standard deviations under 10%.  
 
5.4 Discussion 
This study describes a novel ribozyme-catalyzed 5’ transcript replacement reaction. By 
utilizing the 3’ recognition elements (P9.0 and P10) of a group I intron as the primary 
recognition element (Figure 2.15) between the ribozyme and the transcript substrate, this first-
reported 5’ replacement reaction did, in the small model system, occur. As mentioned 
previously, there are various types of reactions that are catalyzed by group I intron-derived 
ribozymes. Each of these has potential in as treatment options for genetic mutations; however, 
this is the first reaction catalyzed by a ribozyme that has been specifically engineered for 5’ RNA 
transcript replacement. In terms of RNA replacement or repair, this novel reaction offers a 
promising catalytic option. 
 
 74
5.4.1 Length Dependence of P9.0  
From these results, a longer P9.0 helix provided more product formation than a shorter 
P9.0 helix. The RE2 region binds to the 5’ exon that will be replaced, forming the P9.0 helix 
(Figure 5.2A). This interaction targets the 5’ end of the exogenous substrate and moves it into its 
necessary orientation for the 5’ replacement splicing reaction. A stronger P9.0 helix (longer RE2 
length) means more stable targeting of the substrate and a decrease in the possibility of substrate 
and intermediate dissociation, both of which advance the potential for reaction completion. The 
beneficial effect of a longer P9.0 helix in this system echoed previous results shown in a P. 
carinii-derived ribozyme catalyzing an excision-ligation reaction (99).  
 
5.4.2 Length Dependence of P10  
This investigation also showed that a longer P10 helix also enhanced product yield. It has 
been previously reported that 3’ exon binding for a ribozyme derived from the P. carinii intron is 
weaker than that of the 5’ exon for the same system (31). This would correspond with a lengthier 
RE3 region (longer P10 helix, thus stronger interaction) being more helpful in binding and 
holding the 3’ exon region for exon ligation and product formation. An extended RE3 region 
maintains the P10 helix interaction that keeps the 3’ exon in place for the second step of the 
reaction. This lengthened interaction could augment the rate of the reaction by having the 3’ 
exon component ‘pre-organized’ for exon ligation. This finding also corresponded to previous 
work done in the P. carinii-derived ribozyme system mentioned above; an increased P10 helix 
length resulted in greater product formation, with an optimum length of 5 base pairs (31). The 
correlation between these two studies suggests that these length preferences are fundamental to 
reactions catalyzed by the P. carinii group I intron-derived ribozymes.  
 
5.4.3 Length Dependence of L1 Loop Region  
In this system, the original purpose for the sequence of the loop region was to connect the 
new 5’ exon to the ribozyme. It obviously, however, played a role in determining the reaction 
rate, evidenced by a 5-fold increase in the observed rate constant when comparing the original 
ribozyme construct (with a 6-base L1 loop) and the optimized construct (with a 10-base loop). 
The original ribozyme construct differed from the more effective construct at only the loop 
length. The P9.0 and P10 helices were the same. What can also be seen from the change in the 
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reaction rate is that a longer L1 loop also increased the extent of product formation. Tdwo 
possible theories could apply to why the reaction benefited from a longer loop region. The first 
concerns flexibility; perhaps the 10-base loop region provided ample ‘maneuvering room’ for the 
portion of the ribozyme containing the 5’ exon and relieved any strain in the P1 or P10 helices. 
With a loop of 12 or 14 bases, the relieved strain could have turned into a ‘floppy’, unstable 
confirmation that would explain the decrease in product as the loop length increased. The second 
theory has as its basis the similarity between the 10-base loop region and the actual sequence 
(CACCUUCU) of the native L1 loop found in the P. carinii intron in nature. Beyond the first 6 
bases in both loops, the remaining bases were pyrimidines, and perhaps lended a structural 
similarity of the natural conformation of the intron to the optimized ribozyme construct. 
Changing the sequence of the L1 loop to more closely resemble the native intron in this way 
could have served to bring the ribozyme closer to the native state of the intron, and thereby 
increased its activity.  
 
5.4.4 Effect of GMP on 5’ replacement splicing 
The study of GMP’s effect on the 5’ replacement splicing reaction revealed a lowering of 
product levels as the concentration of GMP increased. This obviously differs from ribozyme 3’ 
replacement splicing, which needs GMP for the first step of the reaction. In that system, GMP is 
at a concentration of 100 µM in the in vitro reaction; our investigation shows a 4-fold decrease in 
product at 100 µM (Figure 5.7). Further testing is required to ascertain whether this decrease in 
product is due to direct GMP inhibition of the reaction or to GMP-mediated degradation of the 
substrate and/or reaction product. The TES reaction (derived from the same group I intron), is 
also inhibited by GMP; therefore, evidence exists of a possible inherent trait of GMP-mediated 
inhibition or decrease in product accumulated with the reactions from this class of ribozymes. On 
the flip side of the coin, trans-splicing (ribozyme 3’ replacement splicing) was reported for the 
first time in 1994; yet we report 5’ transcript replacement catalyzed by a ribozyme for the first 
time here. Thus, an impediment to the formation and retention of reaction product in the form of 
GMP inhibition or degradation could also explain why the 5’ replacement splicing reaction has 
not been presented before now, and why it is presented in a system other than those reported with 
ribozyme 3’ replacement splicing. From a practical standpoint, however, this effect could hinder 
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the success of the reaction if it is implemented in vivo, due to the presence of such cofactors 
(ranging from 200-700 µM concentrations) in cellular systems (102).   
 
5.5 Comparison with previous work 
The previously mentioned trans-splicing (TS) reaction, or ribozyme 3' replacement, 
focuses on the correction (by replacement) of mutant 3’ end of an RNA transcript (29). 
Therefore, trans-splicing ribozymes carry a replacement 3’ exon. This reaction also requires a 
guanosine cofactor. Trans-splicing has been shown to work in vitro and in vivo in a variety of 
systems (29, 33, 73-74, 103-108). The reaction rate of the TS reaction in vitro is 0.17 min–1 
(109), as compared to the optimized rate of 9.15 x 10-3 min–1 of the 5’ replacement splicing 
reaction. 
Trans-splicing does, however, possess its own potential limitations. Mutations located on 
the 3’ end of a transcript would be the most reasonable targets for repair. Repair of mutations on 
the 5’ end of a transcript may be attempted, but problems may arise depending on the amount of 
bases that could be effectively carried by the delivery plasmid in an in vivo system. The 5’ 
replacement splicing reaction, in contrast, is specifically designed for mutations on the 5’ end of 
a transcript, providing an alternate avenue for this type of repair. In addition, 5’RS does not 
require a guanosine cofactor. 
As for recognition element investigations, the P10 helix has been implemented in TS 
reactions and found to be beneficial (32). The length of this helix was tested from 0 to 6 base 
pairs, with 6 base pairs as the normal construct. Those P10 helices with 0 and 2 base pairs 
resulted in a drop in ribozyme activity in vivo as compared to the activity shown with 4 or 6 base 
pair helices. These results bear similarity to our findings of lengthier P10 regions proving 
advantageous in the 5’ replacement splicing system, specifically a 6 base-pair P10 helix.  
Considering studies on the effect of L1 loop length, there is a loop region in trans-
splicing ribozymes similar in placement to the one in 5’ replacement splicing ribozymes. One 
study has reported on the effect of its length on cis-splicing activity in mammalian cells (110). 
L1 loop insertions from 4-84 nucleotides were tested for their ability to enhance the splicing 
activity of a Tetrahymena ribozyme in cells. The loop was altered from the native 14 bases up to 
98 bases in length. Loop lengths of 18, 37, 38 bases were the most productive. The study did not 
examine loop lengths shorter than the native loop, however, the finding of an expanded L1 loop 
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region benefiting the reaction correlates with what we report here. The authors of the previous 
report cited changes in ribozyme-substrate flexibility to explain these results.  
Another type of transcript modification, spliceosome-mediated RNA trans-splicing, or 
SMaRT, has been exploited with both 3’ and 5’ exon replacement (111-114). It utilizes a pre-
trans-splicing molecule (PTM), which includes a binding domain and the correct replacement 
RNA sequence for the transcript. It might suffer, however, from certain potential limitations. For 
example, the available splice sites are exclusively at intron-exon junctions. As a result, nuclear 
introns are required for these types of systems. The 5’ replacement splicing reaction, on the other 
hand, does not require that the splice sites reside at intron-exon junctions. Thus its targeting 
capabilities are not limited to only replacing entire intron-exon segments of a transcript or 
restricted from repairing just a portion of an exon.  
 
5.6 Implications  
For the first time, a ribozyme-mediated 5’ replacement splicing reaction has been 
developed that can and does occur. Through investigation of the effect of the P9.0 on the 5’ 
replacement splicing reaction, an 8-base region was shown to result in increased product yields. 
The P10 region can also improve this reaction through elongation; this effect is most apparent 
when paired with a lengthier L1 loop region. A 6 base-pair P10 in conjunction with a 10-base 
loop increases product formation more than 2-fold and the reaction rate over 5-fold. This finding 
provides evidence of a significant role for the loop region, one that can be exploited in future 
studies. The design of this ribozyme reaction is somewhat unique in its reliance on a 3’ 
recognition element of a group I intron as the primary recognition element for the substrate. This 
relationship between reaction success and the molecular interactions creates a better 
understanding of how to manipulate the factors in the reaction to enhance its chances for success.   
The reaction rate is low, compared to the rates of other reactions for the P. carinii system. 
The rate of the native self-splicing intron is 0.9 min–1, while the rate of its suicide inhibition is 
more than 10-fold lower at 0.081 min–1 (115). The TES reaction, which provided some of the 
foundation for this design, has 0.05 min–1 as its lowest rate (33). As low as this rate may be 
compared to the others mentioned here, it is still 5-fold faster than the optimized 5’ replacement 
splicing reaction. Although the rate is relatively low for a group I ribozyme-catalyzed reaction, it 
is different in design from what has previously been done with the P. carinii-derived ribozyme.  
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Another obstacle for this reaction could be effective binding of the 3’ exon. As 
mentioned previously, weaker 3' exon binding has been found in a P. carinii-derived ribozyme; 
this could result in problematic dissociation of the 3’ exon. The 5’ replacement splicing reaction 
obviously requires that the 3' exon remain bound until reaction completion, as its ligation to the 
new 5’ exon creates the reaction product. Thus weaker binding and 3’ exon dissociation may 
play a part in the slower reaction rate and greater requirement for magnesium. Perhaps these are 
tradeoffs needed for a successful reaction. Previous studies present evidence, however, that the 
efficiency of group I intron-derived ribozymes can be increased by insertions and mutations 
(116-117). Some of the possible limitations of this 5’ replacement splicing reaction system could 
be overcome with random mutagenic studies to determine beneficial alterations to the ribozyme.  
The findings discussed here provide additional insight on the inherent aspects of group I-
intron-derived ribozymes, as well as the potential applications of such systems. The most 
obvious and hopeful of the applications for this system deals with the therapeutic pathway. As 
previously mentioned, this reaction system may be examined as a possible treatment of mutation-
related diseases.  
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Figure 5.1. 5’ Replacement splicing ribozyme plasmid design. 5’ 
Replacement Splicing Plasmid Design. The starting plasmid, P-8/4x was 
modified with an Age I restriction site in the region containing the 
ribozyme (Step 1). Step 2 utilized an existing SfiI restriction site and the 
new AgeI site to insert a double-stranded fragment containing the 
necessary elements of the 5’ replacement splicing ribozyme. Step 3 
required 2 rounds of site-directed mutagenesis to alter the RE2 region. The 
finished plasmid is designated PKA; the digits following the base plasmid 
name describe the L1 loop/RE2 region/RE3 region lengths.  
Step 1: Site-directed 
mutagenesis on P-8/4x 
plasmid  to add an Age 
I site
PKA-6/8/6: 5’ 
Replacement Splicing 
Ribozyme
Step 3: Site-directed 
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Figure 5.2. 5' Replacement splicing system design. (A) The 5’ replacement splicing 
ribozyme is in uppercase lettering, with the exon in blue, while the 16-mer substrate is in 
green lowercase lettering and the exon regions to be ligated are in bold. The ribozyme 
recognition element RE1 base pairs with the 5’ exon-ribozyme conjugate to form the P1 
helix (an intramolecular interaction). The ribozyme recognition elements RE2 and RE3 
base pair with the substrate to form the P9.0 and P10 helices, respectively. Arrows in the 
uppermost diagram represent the catalytic sites for the 5’ cleavage and exon-ligation steps. 
The P10 helix is boxed and the L1 loop is circled. The 5’ uridine (blue) and 3’ guanosine 
(gray) that help define the catalytic sites are circled. (B) The small model substrate 
contains codons 18-22 and is denoted with green lowercase letters. The replacement 5’ 
exon attached to the ribozyme is in blue and denoted with uppercase letters; it contains the 
last base of codon 16 through the last base of the new codon 20. This last base is a uridine 
(underlined) in the replacement exon, altering the nucleotide sequence, but not the amino 
acid sequence. The reaction results in a product containing the entire replacement exon 
and two codons from the substrate. Note that the product is 4 bases longer than the 
substrate, which aids in identification. 
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Figure 5.3. Representative gel and optimization data with rPKA-6/8/6. (A) 
Polyacrylamide gel showing product and substrate from the 5’ replacement 
splicing reaction. The plasmid from which the ribozymes are transcribed is PKA; 
the ribozyme itself is denoted as rPKA-6/8/6 (base plasmid-L1 loop/RE2/RE3 
lengths). Reactions were run using 100 nM rPKA-6/8/6 ribozyme, 8 nM 
radiolabeled substrate, and 50 mM MgCl2 at 44 °C for 20 hours. The first lane 
contains the synthetic reaction product; the second lane contains the 5’ 
replacement splicing reaction with the 16-mer substrate yielding the 20-mer 
product. The third lane shows an alkaline digest of the synthetic product, and the 
fourth lane shows the 16-mer starting material under reaction conditions with no 
ribozyme. Shown to the right of the gel are the sequences and the sizes of the 
substrate and product. Note that there is a radiolabeled cytosine on the 3’ end of 
both the substrate and the product. (B) Optimization of the replacement splicing 
reaction with rPKA-6/8/6. The reactions were run as described above except for 
the changing variable. Each data point is the average of two independently run 
assays. The standard deviation for all points is less than 10%. 
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Figure 5.4. P9.0, P10, and L1 loop length dependence data. The diagram 
to the right of each graph shows the structures formed by the recognition 
elements. The reactions were run with 100 nM ribozyme, 8 nM substrate, 
and 50 mM MgCl2 at 44°C for 20 hours. All data points are the average 
of 2 independent assays; the standard deviation for all points is less than 
10%. (A) The effect of P9.0 length on product formation. The longest 
length tested (8 bases) is shown at the right. The RE2 region is shown in 
the diagram in bold lettering. Both RE3 and the L1 loop were each at 6-
base lengths. (B1) The effect of loop length with an RE3 of 6 bases. The 
reactions were run as described above. The longest length tested (14 
bases) is shown to the right of the graph. The RE3 and loop regions are 
shown on the right in bold lettering. The P9.0 was at a length of 8 bases. 
(B2) The effect of loop length with an RE3 of 1 base. The longest lengths 
tested (14 bases) are shown to the right of the graph. The P9.0 was at a 
length of 8 bases.  
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Figure 5.5.  Representative gel and optimzation data using rPKA-
10/8/6. (A) Polyacrylamide gel showing product and substrate from 
the 5’ replacement splicing reaction with rPKA-10/8/6 using 100 nM 
ribozyme, 8 nM radiolabeled substrate, and 50 mM MgCl2 at 44 °C 
for 20 hours. The first lane contains an alkaline digest of the synthetic 
product; the second lane contains the 5’ replacement splicing reaction 
with the 16-mer substrate yielding the 20-mer product. The third lane 
shows the synthetic reaction product; and the fourth lane shows the 
16-mer starting material only under reaction conditions without 
ribozyme. Shown to the right of the gel are the sequences and sizes of 
the substrate and product. Note that there is a radiolabeled cytosine 
on the 3’ end of both the substrate and the product. (B) Optimization 
of the replacement splicing reaction with rPKA-10/8/6. The reactions 
were run as described above except for the changing variable. Each 
data point is the average of two independently run assays, with 
standard deviations below 10%. 
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Figure 5.6. Sequencing protocol design. diagram illustrates the sequencing 
protocol for the small model 5' replacement splicing product. The linkers are 
shown in black and are DNA, the DNA template is shown in gray. The 5' 
replacement splicing product (from reactions using the final ribozyme 
construct) is shown as an open box. The system is designed so that the 
template does not contain a complementary base for the new uridine at the 
splice site; thus, there is a 1-nucleotide bulge.  Once the linkers and 5' 
replacement splicing product have paired with the template, they are ligated 
using T4 DNA ligase. This ligated product is isolated and amplified using RT-
PCR. The primers used correspond with the 5' end of linker 2A and the 3' end 
of linker 1B, respectively. The primers are shown as solid bars. Following RT-
PCR amplification, the product is isolated and ligated into a plasmid. The 
plasmid was then sequenced for product confirmation.  
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subsequent 
ligation with T4 
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Figure 5.7. GMP study. Shown is product observed when using the 
optimized 5’ replacement splicing construct when increasing amounts of 
GMP are added to the reaction. The reactions were run with 100 nM 
ribozyme, 8 nM substrate, and 50 mM MgCl2 at 44°C for 20 hours. Each 
data point is the average of two independent assays with standard 
deviations below 10%.  
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Chapter 6 - Summary and Future Work 
 
 
 Each of the investigations detailed in this dissertation lend additional knowledge to the 
field of nucleic acid studies. They also provide the groundwork for continued studies in the areas 
of DNA ligation, nucleic acid purification, and ribozyme-catalyzed reactions. 
 The study of canonical nucleobases as universal templates in ligation reactions revealed 
reaction conditions that resulted in lowered fidelity for T4 DNA ligase (118). This study also 
reported thymidine as the most consistently effective universal template nucleobase under these 
specific conditions. As previously mentioned, this work could be utilized in the future to develop 
new protocols for the sequencing of oligonucleotides This would require the testing of longer 
templates containing stretches of thymidines in tandem for the ability to direct the sequence-
independent ligation (at the actual nick) of three or more oligonucleotides bound to it. In terms of 
the protocols that presently use DNA ligases and rely on the fidelity thereof, the findings 
presented here impart knowledge of what should be considered when altering reaction 
conditions. As the lowering of the MgCl2 and ATP concentrations results in an obvious reduction 
in fidelity, these are definitely parameters that should be considered in depth whenever altered. 
As for DMSO, it is not always used in those molecular biology protocols that use ligases (44-46). 
Its use in any protocol, however, requiring enzyme fidelity should be considered with caution. 
 The study of 2-butanol extraction as a method of urea removal contributes an efficient 
way to eliminate urea from nucleic acid samples. This procedure could be used as a main 
purification method or as a preparatory step prior to ethanol precipitation or chromatography. 
Butanol extraction could also be tested alongside either of those methods to ascertain a direct 
comparison of efficiency.  
 The novel ribozyme-catalyzed 5’ transcript replacement reaction discussed in this 
dissertation supplies a foundation for future work, for therapeutic applications and to further 
explore group I intron-derived ribozymes. The next step with this work would be its 
implementation in a large transcript system. Such a system would need to be examined to 
compare the reaction in a large model system to the small model system. Once the large 
transcript system has been optimized, in vivo mutagenic studies would need to be done to find 
alterations to the ribozyme that would grant it activity under physiological conditions. This 
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would translate to a lower MgCl2 required for activity, as well as a reduction in the inhibition 
seen when a guanosine cofactor is present with the reaction components. The subsequent studies 
would evaluate the ability of the newer ribozymes to function as a repair method in both bacterial 
and mammalian cells. The 5’ replacement splicing reaction study also gives information as to 
what elements of group I intron-derived ribozymes may be exploited to increase the abilities of 
the catalytic constructs. Longer P9.0 and P10 helices have been shown to benefit more than one 
ribozyme-catalyzed reaction, as have longer L1 loop regions (32, 98, 110). Thus, these 
interactions could be further studied with various sequences to ascertain whether additional 
benefits can be obtained through modification of these molecular aspects.  
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